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Abstract
The PhD thesis concerns the development of scaffolds inspired by biology for muscu-
loskeletal tissue engineering. This was accomplished by chemical modification of poly-
DLγ-glutamic acid (γ-PGA) to reduce its water solubility for use in regenerative medicine
applications.
A series of water-insoluble modified γ-PGA polymers were synthesised, yielding ma-
terials with varying hydrophilicity and dissolution rates. All polymers were fully char-
acterised using techniques such as differential scanning calorimetry, size-exclusion chro-
matography, wide-angle x-ray scattering, thermogravimetric analysis, Fourier transform
infrared spectroscopy, and contact angle determination.
Following characterisation, esterified γ-PGA polymers were oriented to different de-
grees above their glass transition temperatures using tensile deformation. This drawing
induced crystallisation, and thus orientation, on a molecular scale, leading to increased
mechanical properties that were calculated from tensile tests.
Synthesised polymers were found to be non-cytotoxic using the pre-clinical ISO 10993:5
test, and supported human fibroblast cell growth, as determined by LIVE/DEAD® stain-
ing. Oriented, modified γ-PGA polymers were produced with a wide range of mechanical
properties, displaying tailorability for specific tissue engineering applications.
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Chapter 1
Introduction
1.1 Damaged and degenerated tissues
Musculoskeletal diseases and disorders are of growing concern for both tissue engineers
and orthopaedic surgeons. In 2004, the total estimated cost (both direct and indirect) of
musculoskeletal related diseases in America was $849 billion, which comprised 7.7% of
the gross domestic product. [29] These burdens are excepted to increase as the medical
community faces an increasing demand of treating an ageing population.
Injuries to soft tissues, such as tendons, ligaments, or cartilage, lead over 800,000 peo-
ple to seek medical care annually worldwide. [30,31] These aﬄictions most commonly in-
volve the shoulder, ankle, or knee joints, causing pain and debilitation of the patient. [30]
The most common causes of shoulder pain are disease, degeneration, and impingement
of the rotator cuff, a group of four muscles in the shoulder complete with corresponding
tendons which interdigitate to form one common insertion into the humerus of the arm. [32]
Damage to these tendons occurs either through traumatic injury or gradual wear and tear,
often caused by the bony acromion process of the scapula. These tissues have a limited
regeneration capacity and usually require surgical repair to regain arm function. [33]
While some ligaments can heal fairly well, such as the collateral ligaments on the side
of the knee, others require surgical intervention, namely the cruciate ligaments inside
the knee joint. Cruciate ligaments are often repaired or replaced to maintain stability of
the knee joint, which is vital to protection of cartilage tissue. Joint instability is known
to cause premature osteoarthritis, a degenerative disease affecting the articular cartilage
(lining ends of the long bones).
The leading causes of disability aﬄicting the elderly are osteoarthritis and other rheumatic
conditions. In the United States alone, over 47.8 million people live with doctor-diagnosed
arthritis. [34] This number is projected to increase to nearly 67 million people (25% of the
adult population), with 25 million experiencing arthritis-related activity limitations (9.8%
of the adult population). [34]
More specifically, osteoarthritis results in many changes [35], which cause mobility loss,
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debilitation, and a lessened quality of life. [36] Cartilage has poor regenerative capability,
and current clinical therapies focus solely on symptomatic treatment with only one “cure”
of joint replacement surgery. [37] Those aﬄicted in America account for nearly 50% of
joint replacement surgeries each year. [38] Unfortunately, implants have a finite lifespan
owing to loosening of the prosthesis, requiring further surgery and increasing morbidity
of the patient. [36,37]
The future of medical treatment for osteoarthritis and other disorders requires a focus
on regeneration of diseased and damaged tissues, which has the potential to improve
patients’ conditions, disability, and thus quality of life.
1.2 Tissue engineering
Tissue Engineering is an exciting, relatively new field of research with the ultimate aim to
make a three-dimensional cell-containing “scaffold” that can be implanted into the body
to cure a disease or repair a defect. [39] This discipline also has the potential to change the
face of medicine: reducing the need for organ transplantations, speeding up development
of drugs and medical devices, or eventually even replacing organ transplant altogether. [40]
Figure 1.1: The typical tissue engineering approach: 1) Remove cells; 2) Expand number
in culture; 3) Seed onto an appropriate scaffold with suitable growth factors and cytokines;
4) Place into culture; 5) Re-implant engineered tissue repair damaged site. Figure used
with permission from author. [1]
A general example of tissue engineering using autologous cells is shown in Figure 1.1
Cells are removed from the patient, grown up in culture, seeded and cultured on a type
of bioactive scaffold, and then surgically re-implanted in the body. While these steps
are considered key factors, some research is focused on creating a bioactive, biomimetic,
and cell-free scaffold to implant directly into the body. This eliminates both the need for
harvesting cells from the body and cell culture. Scaffolds can be modified with biological
signals to incorporate better with the implant site.
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One goal of researchers is to use a scaffold that will slowly degrade at the same rate of
native host tissue regeneration. Different tissues in the body have diverse compositions
of the surrounding extracellular matrix (ECM). This poses another challenge for tissue
engineers to make tissues, whereby a scaffold intended for bone would not suit liver,
cartilage, or nerve regrowth.
Defects of tissue resulting in loss or failure have been treated with surgical manipula-
tions of tissues or organs. Often referred to as grafts, the obtained tissue is named for its
location of origin. If acquired and implanted in the same patient, it is called an autograft;
if implanted in an individual of the same species, it is an allograft; if placed in a different
species, a xenograft. [41]
While each source has their advantages and disadvantages (Table 1.1), there is a distinct
need for tissue engineering to improve upon these choices. Surgery to obtain tissue for
implants is expensive and carries risks for the patient. The Food and Drug Administration
(FDA) in the United States has already granted approval for some polymers to be used
in the body, with which scaffolds are produced easily and at low cost. Unfortunately,
proteins adsorb non-specifically to the polymers in their native state, and cell-binding
motifs do not exist on the polymers, so there is a need to functionalise these polymers for
enhanced tissue incorporation.
Table 1.1: Examples of advantages and disadvantages of graft or tissue engineering con-
struct origin.
Scaffold Source Advantages Disadvantages
Autograft Little to no immunorejection Limited donor sites
(Same patient) Considered ”gold-standard” for Extra surgery to obtain tissue
tissue choice [41] Increased donor-site morbidity
Expensive
Allograft Same species, likely to incorporate Possibility of pathogen transfer
(Same species) Tissue can be obtained from More likely to experience
donors not aﬄicted by the immunorejection than autograft
disease of the recipient Procurement of tissue is complex
and expensive
Xenograft Large amount of tissue availability Possibility of xenozoonosis (pathogen
(Different transfer from another species) [42]
species) Highly likely to elicit immune response
Issues of incorporation into host tissue
Artificial Cells can be seeded and May be recognized as a foreign body
(Polymer origin) cultured on the scaffold and elicit an immune response
Naturally degraded by the body Unfunctionalised, often hydrophobic
Easy to produce in bulk No blood vessel formation within
FDA approved polymers artificial polymer network
Cheap to produce
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1.2.1 Musculoskeletal tissues
Bone
There are two types of bone in the body, distinguished by their density: cortical (often
called compact) and trabecular bone (spongy, or cancellous). Cortical bone consists of
concentric rings of matrix circumventing both central and perforating canals, while tra-
becular bone has bone marrow filled amongst the irregular, porous lattice structure. [43]
A natural composite of inorganic hydroxyapatite and organic matrix, bone can withstand
both tensile and compressive forces. The organic extracellular matrix is mostly colla-
gen (90% total ECM, with 97% type I and 3% type III collagen) while 10% is com-
posed of other non-collagenous proteins, namely osteocalcin, osteonectin, proteoglycans,
fibronectin, growth factors and more. [44] The collagens contribute to tensile properties,
while the mineral crystals increase the hardness and toughness of the tissue. [43]
Bone is a dynamic tissue, constantly remodelling itself in response to mechanical stim-
ulation. Three types of cells exist in bone, osteoblasts (form bone), osteoclasts (resorb
bone), and osteocytes (highest population of cells in bone; translate mechanical stimula-
tion into chemical signals that affect bone renovation [45–47]). The cells control the balance
of storing and releasing calcium for use in the body, however this is disproportional in
osteoporotic patients and more bone is resorbed. This results in less dense bone which is
more brittle and thus prone to fracture.
If a patient experiences a loss of bone from cancer or trauma, the defect may be too
large to regenerate, requiring an implant in the damaged site. One option is transplan-
tation from another area in the body, but this is limited due to limited availability of
non-weight bearing bone, donor site morbidity, increased pain and recovery time for the
patient, and risk of additional surgical complications. [48] Tissue engineering could pro-
vide an alternative option to replace the damaged or missing tissue, assisting the bone in
its regeneration.
Cartilage
Prone to damage, articular cartilage (hyaline cartilage) also has a poor ability to repair
itself and injuries often lead to an earlier onset of osteoarthritis. [37,49–51]. A commonly
used treatment, called microfracturing, involves cracking the underlying bone surface to
induce repair. Unfortunately, the cartilage formed is often fibrocartilage, which has poor
mechanical properties and integration with the native hyaline tissue. Autologous cell
transplantation also appears to fail long-term in repairing articular cartilage defects. Better
techniques for cartilage repair are needed to prevent or treat premature osteoarthritis.
Articular cartilage is mainly acellular, with chondrocytes only comprising about 2% of
the total cartilage volume in adults. [52] It also is organized into three zones, differing in
composition, organisation, and cell concentration (Figure 1.2). [2] Cartilage is avascular
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and chondrocytes are dependent on successful nutrient and oxygen diffusion through its
extracellular matrix (ECM).
Chondrocyte metabolism operates at low oxygen tension within the cartilage matrix,
ranging from 10% at the surface to less than 1% in the deep zones. During physiological
hypoxia, the hypoxia inducible factor-1α acts as a survival factor for the chondrocyte in
the avascular cartilage matrix, permitting maintenance of homeostasis and the capacity to
respond to environmental change. [53] These properties of cartilage are key challenges that
researchers must address with scaffolds and tissue engineering.
Figure 1.2: Hierarchical organisation of cartilage. A) Articular cartilage covers the ends
of long bones B) with distinct zonal organisation of C) collagen structure. Resident D)
Chondrocytes are surrounded by a matrix of E) aggrecan/hyaluronic acid super-aggregates
and macrofibrillar collagen networks. Adapted from [2] with permission. Copyright 2004,
AAAS.
Connective tissues
Two types of connective tissue are of interest in musculoskeletal tissue engineering: lig-
ament, connecting bone to bone, and tendon, which connects muscle to bone. [3,54] Liga-
ments determine the range of motion which the joint can endure before rupture. [54] In con-
trast, tendons transmit forces generated by muscles to bone, resulting in skeletal motion
and stability of the joint. [54,55] Ligaments are key passive joint stabilisers, while tendons
can actively store and return elastic energy. [54,56]
Collagen type I is the predominant solid constituent of ligaments and tendons (typically
greater than 75%), and may compromise up to 99% of the dry weight in some tendons. [55]
While ligaments and tendons appear similar, there are differences which greatly affect
their function. In 1984, Amiel et al. performed a histological and biochemical comparison
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between rabbit tissues, [57] which helped to distinguish that these tissues are not as similar
as previously thought. They found that tendons contained more collagen type I, less
glycosaminoglycans (GAG), less DNA, and a different collagen cross-linking pattern than
ligaments. [57] On the other hand, ligaments contained more type III collagen (attributed to
be less mature), more GAGs, larger and more cells, and a collagen cross-linking pattern
similar to granulation tissue (involved in wound healing). [57]
Due to the nature of their purpose of transmitting forces to and from bone, both tissues
must endure an interfacial gradient change to integrate well into bone. The mechanical
properties of the tissues are drastically different, seeing as bone responds to compression
while ligaments and tendons are very strong in tension. [3,54,58] Thus tissues have developed
gradual changes (Figure 1.3) to prevent stress concentrations, namely using fibrocartilage
as a transition. Moffat et al. reported that the mineralised transition in fibrocartilage
transfers compressive load. [59] Young’s modulus was been shown to increase across the
juncture, with the mineralised fibrocartilage withstanding significantly higher compres-
sion. [3,59] This demonstrates a common challenge for tissue engineering applications, as
improper fixation, integration, or distribution of mechanical properties would cause an
imbalance in force transfer and ultimately lead to failure.
Figure 1.3: Diagram adapted from [3] detailing tendon/ligament-bone and muscle/tendon
interface compositions including aggrecan (orange), collagen fibres (light blue), miner-
alised tissue (dark blue) and muscle fibres (red).
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1.2.2 Tissue mechanical properties
In order to target specific tissues, engineered constructs should also take into account the
native mechanical properties. For example, titanium alloy implants, the current gold stan-
dard bone replacement, are orders of magnitude stiffer than the tissue itself. As a result,
the implant bears the majority of mechanical loading, leading to stress shielding within
the bone. [60] As mechanical stimulation is necessary to maintain healthy bone tissue, this
discrepancy can result in loss of bone around the implant, causing loosening and, ulti-
mately, failure of the implant. Therefore, researchers must also be aware of the native
tissue properties to appropriately tailor the replacement product.
Figure 1.4 compares bulk mechanical properties of hard (mineralised) and soft (un-
mineralised) human tissues subjected to tensile testing in a plot modelled after Ashby et
al., [61] while Figure 1.5 presents materials commonly used as tissue replacements.
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Figure 1.4: Ashby-style plot of stiffness versus tensile strength of human tissues tested in
tension using data taken from [4–24]
Figure 1.5: Ashby-style plot of stiffness versus tensile strength of biomaterials commonly
as tissue replacements, using data taken from [4–24]
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1.2.3 Cell sources
Stem cells
Several cell types can be used in tissue engineering, depending on the desired outcome of
the engineered construct. In recent years, researchers have been investigating the potential
of stem cells. The two most common classifications of stem cells are adult stem cells and
embryonic stem cells. Haematologists treating leukaemia with bone marrow transplants
first discovered adult stem cells, and today the two most common adult stem cells are
haematopoetic stem cells (HSCs) and mesenchymal stem cells (MSCs or marrow stromal
cells). [39,62,63]
On the other hand, embryonic stem cells (ESCs) are derived from a blastocyst, a ball
of cells formed after fertilisation. These cells have generated lots of ethical debate sur-
rounding their origin, and as such the first human ESCs were developed in 1998 while
murine ESCs were developed in 1981. [39,64] Termed ‘pluripotent’, ESCs have the ability
upon dividing to become any cell in the body, based on the culturing environment, while
also retaining their ability to divide indefinitely in an undifferentiated state. [39] For tissue
engineers this is exciting because ESCs have the potential to provide an unlimited source
of cells, whereas adult stem cells have a limited dividing capacity. [39]
Lately, the periosteum has been gaining attention in tissue engineering. The perios-
teum is a multi-layer tissue that serves as the boundary between the long bones and the
surrounding soft tissues and contains multiple cell types. [65] Within the cambium layer
of the periosteum, researchers have found cells that appear to be stem-cell like, with the
ability to generate into other tissues such as bone and cartilage. [66–72] This is also another
potential source of cells for regenerative medicine.
Primary cells
Osteoblasts might be an attractive source for bone tissue engineering as they synthesise,
secrete, and mineralise matrix to form bone. Derived from bone marrow, osteoblasts
mainly synthesise collagen type I, but also produce growth factors and other proteins
necessary for healthy bone formation. [73] Unfortunately, once they are embedded in their
formed matrix, they either experience apoptosis or differentiate to form osteocytes, which
resemble nerve cells and are also known as inactive osteoblasts. [73,74]
Chondrocytes are a potential source of cells for cartilage tissue engineering. Native to
articular cartilage, these cells seem an ideal source, and autologous cartilage transplan-
tation has recently been used as a clinical therapy for osteochondral defects. [51,75] Unfor-
tunately, due to chondrocytes’ limited regenerative capacity, this treatment is unsuitable,
and the surgery required to obtain cartilage is associated with donor-site morbidity. [75]
Furthermore, osteoarthritic patients will typically have limited amounts of viable articu-
lar cartilage available for harvesting.
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Hui et al. [75] have investigated several therapies for repairing chondral lesions, includ-
ing using chondrocytes and MSCs transplants, periosteal grafts, and mosaicplasty (osteo-
chondral autograft) in rabbits. This group found that while osteochondral autografts did
well initially, the periosteal grafts did ”less than favourably”, and the chondrocytes and
MSCs, encapsulated in a fibrin glue, had comparable enhancing effects of hyaline carti-
lage. [75] While chondrocytes and MSCs had comparable effects, chondrocytes have little
to no regenerative capacity, making MSCs a more ideal cell choice.
Ligament and tendons are sparsely populated, yet the main cell type found in these tis-
sues is the fibroblast. Responsible for collagen production, these cells are elongated and
well known to align in the direction of collagen fibre orientation. Fibroblasts upregulate
genes responsible for matrix proteins in response to injury, generating randomly organ-
ised, fibrous scar tissue. [76] Fibroblasts also respond to mechanical stimulation, producing
more matrix as a result of mechanotransduction. [77] In addition, these cells are responsi-
ble for reorganisation of the extracellular matrix, so in advanced healing they degrade and
replace the scar tissue with newly synthesised, organised matrix. [76] Despite their ability
to generate large amounts of extracellular matrix, fibroblasts have a low mitotic rate, [31]
thus are not ideal for tissue engineering applications.
1.2.4 Extracellular matrix and cellular interactions
Central to tissue engineering, researchers are coming to realize that the ECM plays a
vital role in cell and tissue growth. The nanoscale ECM structure in the body provides a
natural web of intricate fibre-like nanostructured proteins to support cells and present an
instructive background to guide their behaviour. [38] The ECM is composed of mainly three
classes of biomolecules: (1) structural proteins, collagens and elastin; (2) specialized
proteins, such as laminin and fibronectin; and (3) proteoglycans, which have a protein
core with many disaccharide chains attached called glycosaminoglycans. [78] Researchers
must produce a three-dimensional scaffold that encourages cells-ECM interaction, allows
sufficient nutrient diffusion, and supports tissue ingrowth.
The outer membrane of an animal cell is usually covered with specific signalling pro-
teins and carbohydrate structures. It also has at least six different receptor systems that
can be activated in several ways, such as interactions with ligands in the ECM, neigh-
bouring cells, or soluble signalling molecules. [38] Integrins are an important example of a
transmembrane protein receptor, consisting of a combination of one α-subunit and one β-
subunit. There are 18 known α- and 8 β-subunits, from which 24 pairs are characterised.
The specific combinations of subunits determine the ligand specificity, though some are
less specific than others. [79,80]
Upon binding to the ECM, integrins undergo activation via conformational change, trig-
gering numerous signal transduction pathways that serve to regulate many aspects of cell
behaviour: cell proliferation, differentiation, gene expression, shape, polarity, motility,
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and survival/apoptosis. [81] The cytoplasmic tails of integrin subunits are generally short
and adapter proteins associate with the tails to connect the integrins to the cytoskeleton.
Once attached, the cell spreads, and integrins begin to cluster together, successfully an-
choring the cell to the ECM. The actin filaments inside the cell reorganise into larger
stress fibres, and acting as a positive feedback system, the number of clustering integrins
increases until proteins on either side of the integrins form well-developed aggregates
known as focal adhesions. [82]
One well-studied ECM protein motif that nearly half of the 24 integrins bind is Arginine-
Glycine-Aspartic Acid (RGD). RGD exists in many ECM components, such as collagen,
laminin, osteopontin, vitronectin, and fibronectin. [79] RGD peptides were first found to
promote cell adhesion in 1984 [83], and since then many materials have been function-
alised with RGD. Stable linking of RGD peptides to a surface is necessary to promote
focal adhesions as their formation only occurs if the ligands can withstand the cells’ con-
tractile forces. [79,84–87]
Other short peptide sequences which mimic ECM components have been studied as
candidates for functionalising surfaces for biomaterials and tissue engineering. [88] In 1991,
Staatz et al. identified the sequence DGEA as a collagen type I binding peptide. [89] This
sequence has gained popularity in recent years for bone [90] related applications, and some
groups have even looked to DGEA to direct stem cell differentiation. [88,91,92]
Other peptide sequences pertaining to collagen type I and bone have been identified,
such as P15 [93] and GFOGER [94]. The sequence of P15 comes from a biologically active
region of a type I collagen alpha-1 chain, namely amino acids 766-780, and is involved
in bone formation. [93,95] Similarly, GFOGER also has a positive effect on bone cells, and
even promotes improved osseointegration of functionalised implants in vivo [96,97].
Identification of matrix mimicking protein sequences and their effect both in vitro and
in vivo is advantageous for making tissue engineered constructs more like the native ECM.
While synthetic polymers can be produced with the same morphology as the ECM, they
lack the necessary cellular signals. Therefore, there is a prominent need for biofunc-
tionalisation of these polymers in tissue engineering. Relevant fragments that have been
identified to have a positive effect, much like the whole biological protein, provide an
option to functionalise synthetic polymers for better cellular and tissue integration.
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1.3 Polymers and their role in tissue engineering
1.3.1 Scaffolds
Scaffold requirements
The scaffold is a temporary supporting structure for growing cells and tissues. [41] Just like
the ECM, the artificial scaffold must play a vital role in tissue growth and cell prolifer-
ation. An ideal scaffold would possess all the characteristics and functions of the ECM
under physiological conditions. Tissue-specific structure and properties are exhibited in
the native ECM’s complex and dynamic environment, filled with nano-sized features of
pores and fibers. [38,41,98] Some basic characteristics are listed below in Table 1.2.
Table 1.2: Basic characteristics of a perfect tissue engineering scaffold.
Characteristics General remarks
Biodegradable Degradation rate must equal the rate of tissue regeneration
Biocompatible (non-toxic) Material should not cause any inflammatory or toxic response
and any byproduct of degradation should not harm native tissue
Porous 3-D structure Assist cellular ingrowth & allow adequate oxygen/nutrient supply
Chemically modifiable Functionalise chemical or peptide sequences to improve cell
adhesion or direct cell growth & differentiation
Mechanical properties Provide support for regenerating tissue while generating
appropriate mechanical stimulation
Sterilisable Using common medical techniques for medical implants
1.3.2 Polymers to use for scaffolds
Material selection is one of the most important factors for tailoring a scaffold to a spe-
cific tissue. Currently, there is an immense array of biocompatible materials that can be
used to construct a scaffold. Several factors of these materials, such as degradation rate,
mechanical properties, hydrophilicity, cell adhesion and cell proliferation are necessary
considerations when choosing one for engineering a specific tissue. [99]
Synthetic polyesters
Poly(lactide) (PLA) is the polymer produced from the cyclic diamer of lactic acid. Two
isomers exist, D (dexorotary form, PDLA) and L (levorotoary, PLLA, naturally occurring
form), and the polymer is formed by ring-opening polymerisation. [100] A synthetic blend
of D,L-lactide can also be formed, though it makes an amorphous polymer. PLLA is
a very hydrophobic, semicrystalline polymer, and has a degradation time of one to two
years in the body. [100] All isomers degrade by hydrolysis into lactic acid, which can be
removed from the body by regular metabolic processes.
Poly(lactide-co-glycolide) (PLGA) is a copolymer formed from the cyclic diamers of
lactic acid and glycolic acid by ring-opening polymerisation. For a PLGA copolymer, it
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is important to note that a linear relationship between composition and degradation time
does not exist [100,101]. PLGA also degrades by hydrolysis into lactic acid and glycolic acid
that are removed by metabolic processes in the body.
Poly(ethylene glycol) (PEG) is a very hydrophilic polymer of ethylene glycol, pro-
duced by polycondensation step polymerisation. [102] PEG is commonly used in drug de-
livery, tissue engineering, and can be used to increase the hydrophilicity of a polymer
blend. PEG is non-toxic, non-immunogenic, and non-antigenic. [103] PEG also has a pro-
longed residence in the human body, decreased degradation by metabolic enzymes and a
reduction or elimination of protein immunogenicity. [103]
Poly(-caprolactone) (PCL) is a semicrystalline polymer, produced by ring-opening
polymerisation. PCL has a lower melting temperature than PLA, but has a degradation
time of around two years. [100] PCL also degrades by hydrolysis, and could be a promising
polymer for tissue engineering, but it is unfunctionalised and hydrophobic. The formation
of PCL and other polymers is shown in Figure 1.6.
Some feature all hydrophobic, FDA-approved polyesters have in common is their degra-
dation mechanism, acidic byproducts, and unfunctionalised polymer backbone. Further-
more, their degradation products may build up in tissues, causing a drop in pH, which
can catalyse the hydrolysis, resulting in bulk degradation of the scaffold and a drastic loss
of mechanical properties. Polyesters are also well known to cause cysts from the acidic
buildup in bone tissue. [104] Thus, alternative polymers that may be functionalised, degrade
in a more-controlled manner, and release byproducts which are more tolerable than those
from polyesters are of interest in tissue engineering.
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Figure 1.6: Synthesis of FDA approved polyesters. A) PLA, B) PLGA, C) PEG, D) PCL.
Naturally produced polymers
Many researchers have concluded that further functionalisation is necessary to mimic the
ECM as well as producing scaffolds with features of the same size. Natural polymers
have been used as tissue scaffolds as they may retain the necessary cues for cells from the
ECM. For example, groups have successfully fabricated scaffolds from fibrinogen, [105,106]
hyaluronic acid, [107,108] chitosan, [109] collagen types I [110–113] and II [114,115] chondroitin sul-
fate, [112] DNA, [116] gelatin, [117,118] and silk. [119–122] Unfortunately, these natural polymers
are very expensive to purchase and often, their mechanical properties are decreased from
those in the native ECM. Some components fundamental to cartilage, such as collagen
type II or hyaluronic acid, are not practical to make scaffolds solely of the single polymer
and usually need to be strengthened after fabrication.
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Poly-γ-glutamic acid
Poly(γ-glutamic acid) (γ-PGA) is a non-toxic, [123,124] natural polymer synthesised by sev-
eral Bacillus species, two archea, and few eukaryotes. [125] In fact, γ-PGA has even been
discovered to be linked to α-tubulin in murine neurons as a post-translational modification
of a glutamic acid polymer consisting of 455 subunits. [125,126] Janke et al. identified sev-
eral polyglutamase enzymes involved in this modification and found they were necessary
for neurite outgrowth [127]. Furthermore, Rogowski et al. discovered this is a reversible
process which must be balanced, [128] between polyglutamylases and deglutamylases, as
hyperglutamation results in neurodegeneration. [129]
Poly(γ-glutamic acid) is a polyamino acid where the glutamic acid residues are linked
via a peptide bond through the γ-carboxyl group (Figure 1.7). One attractive feature is
the free α-carboxyl group which both renders the γ-PGA very water soluble and opens
numerous possibilities for chemical functionalisation of the polymer. At neutral pH, the
polymer is anionic and highly soluble as an ionic salt, such as the readily available Na+
salt form produced by Bacillus subtilis. Other highly water soluble forms Ca2+, K+, Mg2+,
and NH4+ have also been discovered. [130]
Figure 1.7: γ-PGA, protonated at pH < 4.2, and anionic at higher pH values.
Several industries have extensive uses for γ-PGA, including cosmetics, food, water
treatment, drug delivery, heavy metal chelation, agriculture, biodegradable plastics, med-
ical adhesives, vaccines, and tissue engineering. Popular foods in Japan (natto) and Korea
(chungkookjang), fermented soybeans using strains of Bacillus subtilis utilise the γ-D,L-
PGA which is produced as gooey, extracellular mucilage. [130,131]
Since the initial discovery in 1937 by Ivanovics and Bruchner [132] in the capsule of
Bacillus anthracis, [125] researchers have cultivated γ-PGA production in Bacillus sub-
tilis. This bacteria yields a semicrystalline polymer with a racemic mixture of D- and L-
subunits, whereas that from Bacillus anthracis is only formed from D-subunits and com-
pletely crystalline. [125,133] Depending on the culture conditions, the ratio of enatiomers
may be optimised for the desired application. In the same way, the weight-average molec-
ular weight (Mw) of the resultant polymer depends on which strain is cultured and salt
content in the media. For example, Sung et al. discovered that at high concentrations of
NaCl, Bacillus subtilis produced very low Mw γ-PGA (10-200 kDa with more than 10%
NaCl). [124] Today companies sell γ-PGA produced by Bacillus subtilis with a Mw of over
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to 2 million Da.
With tissue engineering applications in mind, one attractive feature of γ-PGA is that it
degrades by enzymes rather than hydrolysis. [134–136] This offers an advantage over FDA
approved polyesters, which degrade by random hydrolysis of the polymer chain as dis-
cussed in the previous section. The enzymatic degradation of γ-PGA has the potential to
be tailored, allowing for a more gradual decrease in mechanical properties as the tissue
regenerates.
In 1954, Kream et al. studied the enzymatic hydrolysis of γ-PGA produced by Bacil-
lus subtilis. As γ-PGA was used either for a sedimenting agent of red blood cells from
plasma or an extender of blood plasma volume, they incubated various human tissues
with γ-PGA and evaluated their digestion of the polypeptide by testing for free glutamic
acid molecules. [134] They found that whole human blood, brain, kidney, spleen, and liver
tissue all digested the γ-PGA , while plasma and muscle did not, therefore they concluded
that red blood cells are likely to contain enzymes which degrade the polypeptide. [134]
There is an apparent lack of in vivo studies identifying the specific mammalian enzymes
which act upon γ-PGA produced by Bacillus subtilis in the literature. Thus, the specific
mechanism of degradation in large mammals and humans is unclear and should be further
investigated.
1.3.3 Scaffold fabrication methods
There are numerous methods to fabricate polymer scaffolds for use in tissue engineering.
Some techniques commonly used [137,138] include gas foaming, [139], fiber bonding, [140],
thermally induced phase separation, [141] porogen leaching (salt leaching), [142] rapid pro-
totyping (computer-assisted deposition), [143] freeze drying, [144] and electrospinning. [145]
Each technique has advantages and drawbacks when cross-compared, however as each
tissue has specific requirements, choosing a method of fabrication should be approached
with an ideal, appropriate application in mind.
1.4 Summary
Tissue engineering has the potential to change modern medicine by encouraging the hu-
man body to repair itself. With many aspects to consider including tissue-specific re-
quirements, this interdisciplinary field requires a breadth of knowledge from materials,
mechanics, chemistry, biology, medicine, and engineering. Whether using a scaffold
that is cell-free, cell-containing, or only cells, many approaches are being researched.
Biodegradable scaffolds provide a framework upon which cells secrete matrix to regener-
ate damaged or diseased tissues. Tailorability of materials to target multiple applications
also offers flexibility to address patient-to-patient variations often seen in medicine. It is
the purpose of this thesis to address chemical and mechanical tailorability of a biopolymer
for use in various tissue engineering applications.
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Scope of thesis
The ultimate goal of this research is to develop a novel material for the repair of tissues
in regenerative medicine. The use of biomaterials to act as a framework upon which
cells grow and deposit extracellular matrix (ECM) while the biomaterial degrades, allows
tailoring of many properties for specific biomedical applications.
In all the studies presented here, research focuses on utilising a natural, biodegrad-
able polymer produced by bacteria, making it suitable for use in tissue engineering.
Poly(gamma-glutamic acid; γ-PGA) is a non-toxic polymer that undergoes enzymatic
degradation. This method is advantageous over commonly used polyesters, which un-
dergo random hydrolysis. Polyesters release acidic byproducts that cause a drop in the
local pH, leading to a more harsh environment for cells to live in. One example of an
adverse reaction to their degradation is cystic formation in bone tissue, where byprod-
ucts have a slow rate of removal. [104] Furthermore, this drop in the local pH catalyses the
polyester construct degradation, leading to a bulk loss in mechanical properties. It is an-
ticipated that using γ-PGA will degrade in a more controlled manner and the amino acid
byproducts released will be more tolerable in the local environment.
The γ-PGA macromolecule contains a simple -COOH side group in the monomer, ren-
dering it highly water soluble, which may be a problem in some tissue engineering ap-
plications, particularly when a water-insoluble scaffold is required. Fortunately, this side
group can be modified, functionalising of the native polymer and changing its proper-
ties. In this work, this -COOH side chain was esterified using three groups, as shown
previously [146] to produce a water-insoluble ‘scaffold’ for use in the human body. Though
esterification of γ-PGA has been around for nearly two decades, nobody has investigated
this modified material for tissue engineering applications.
All modified polymers were found to be both non-cytotoxic and support human cell
growth. This method of chemical modification also enabled the polymer to be drawn
using tensile deformation, a common technique used in industry, resulting in mechanical
properties that could be tailored over an order of magnitude.
In this thesis, the first chapter serves to provide background information on tissue
engineering, including considerations necessary for regenerative medicine, mechanical
properties and composition of human tissue, currently used biomaterials, and methods of
scaffold fabrication. Chapters 2-6 discuss the experimental results of this thesis, include
study-specific experimental methodologies, and provide suggestions for future work. Con-
clusions and a general overview of future developments are discussed in the final chapter.
Two different methods of γ-PGA modification are described in this thesis. The first
technique involves esterification of the -COOH side group and follows the previously
described synthesis by Kubota et al. to reduce the high water solubility of the native γ-
PGA polymer. The second synthesis technique highlights the first time γ-PGA has been
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fully conjugated with an amino acid through the side chain via a peptide bond. This novel
synthesis paves the way for full functionalisation of γ-PGA with amino acids or peptide
sequences. Between the two chapters, disparate functionality of γ-PGA is demonstrated
in modifying this polymer for use with tissue engineering applications.
Each experimental chapter highlights are as follows:
Material synthesis and characterisation
Chapter 2 addresses the need for reducing water solubility of the polymer for adequate
use in tissue engineering. Using a previously described synthesis method, [146] the γ-PGA
was esterified using either an alkyl or aryl group. This chemical modification was struc-
turally and thermally characterised, and results are presented here.
Chapter 3 highlights utilisation of a different modification of γ-PGA, using a two-step
carbodiimide synthesis to fully conjugate L-Phenylalanine*HCl, demonstrating amino
acid functionalisation. The synthesis, structural and thermal characterisation are dis-
cussed in this chapter.
Biological studies and feasibility in tissue engineering
Building on the previous chapter, the feasibility of modified γ-PGA for use in tissue
engineering was examined in chapter 4. To assess toxicity of the chemically modified γ-
PGA , an international standard pre-clinical test for cytotoxicity (ISO 10993:5) was run on
unoriented, modified γ-PGA films. This test is generally used to determine if materials are
suitable for in vivo studies. [147] For cell viability studies, human foreskin fibroblasts were
cultured for 7 days on modified γ-PGA . The ability of this material to support cell viable
growth and proliferation was evaluated using a LIVE/DEAD® assay. Immunostaining
was performed to image the cytoskeletal organisation of these cells on the polymer.
Dissolution soaking studies were performed for 28 days in three different media to
determine any hydrolysis of the modified ester side chain. Mass loss, optical changes,
and surface changes were measured and reported in chapter 4.
Increasing mechanical properties and production
Chapter 5 investigates the capability of tailoring mechanical properties of esterified γ-
PGA, produced as in chapter 2, by utilising tensile deformation, a powerful method to
investigate mechanical properties and produce highly-aligned molecular structures with
ultra-high tensile strength. [148] Here, thermal, structural, and mechanical characterisation
results are presented, demonstrating tailorability of esterified γ-PGA polymers.
Finally, chapter 6 focuses both on increasing the batch size of esterified γ-PGA and
decreasing batch-to-batch variability, employing a different experimental setup to increase
yield and repeatability of these batches. Necessary for further translation of this work
from the laboratory to industry, this chapter presents the structural and thermal results
achieved in scaling the synthesis.
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Reduction of poly-γ-glutamic acid water
solubility via side chain esterification
2.1 Introduction
This chapter investigates chemical modification of poly(gamma-glutamic acid) (γ-PGA)
to decrease water solubility of the polymer. As discussed in Section 1.3.2, γ-PGA is a
water-soluble, edible, nontoxic, and biodegradable poly-γ-amino acid produced by many
Bacillus species. Depending on the choice of bacteria, differing enantiomeric positions
of γ-PGA can be obtained. For example, Bacillus subtilis synthesises γ-D,L-PGA, while
Bacillus anthracis produces only D-enantiomer γ-PGA [149].
Of particular interest with γ-PGA is the enzymatic [134–136] degradability, while FDA-
approved polyesters undergo random hydrolytic degradation. Acidic by-products of poly-
ester degradation can also lead to autocatalysis [150–152] and thus a loss of bulk properties in
scaffold material. In contrast, the degradation mechanism of γ-PGA does not experience
autocatalysis from polymer by-products.
The high water solubility of γ-PGA limits its’ use in tissue engineering scaffold appli-
cations as it readily dissolves in minute amounts of water. Thus modification of γ-PGA is
necessary to avoid dissolution of fabricated scaffolds. Fortunately, the -COOH side group
in γ-PGA provides a site for functionalisation of the polymer, as discussed in Section
1.3.2. To reduce the water solubility for use in scaffolds, this chapter focuses on esterify-
ing the -COOH side chain with either alkyl or aryl groups, as previously reported [146,153].
While Kubota et al. pioneered synthesis of water-insoluble γ-PGA, this material has yet
to be investigated for tissue engineering applications.
Esterification of biological polymers has become popular in recent years. In the late
1940’s and early 1950’s, synthesis of methyl esters of hyaluronic acid and chondroitin sul-
fate were published, though potential applications of these materials were unclear. [154–157]
Several decades later, in 1993, esterification of hyaluronic acid was first published for
tissue engineering applications under the name HYAFF® (registered by Fidia Farmaceu-
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tici s.p.a.) [158] The most popular of esterified hyaluronic acids, HYAFF 11®, is a fully
benzyl-esterified polymer that has medical approval for use in Europe.
Similarly, this work aims to utilise esterification to enable γ-PGA for use in tissue engi-
neering. This synthesis chapter presents the chemical, structural, and thermal properties
of γ-PGA polymers modified by esterification to limit their water solubility.
2.2 Experimental
2.2.1 Chemical synthesis
General
All starting polymer (γ-D,L-PGA Na+ salt, produced by Bacillus subtilis) was purchased
from Natto Biosciences (Shanghai, China). All reagents and solvents were purchased
from Aldrich and used as received, unless otherwise specified.
Free acid form of γ-PGA
γ-PGA Na+ salt (10 g) was dissolved in 250 mL of distilled water. The solution was
acidified with HCl 6M to pH 1.5 and lyophilized for at least 96 h. The freeze-dried
material resulted in a soft and porous solid.
γ-PGA esterification
γ-PGA free acid (+ NaCl) (2.4 g, 0.01 mol) was introduced into a 250 mL round bottom
flask equipped with a thermometer and a magnetic stirrer, and suspended in 180 mL of
anhydrous N-Methyl Pyrrolidone (NMP). The suspension was heated by oil bath to 80°C
and stirred for 24 h. After that time, the mixture was cooled to 60°C and NaHCO3 (4.3
g, 0.28 M) was added. After 2 h, the corresponding bromide (ethyl, propyl or benzyl
bromide to make γ-PGA-Et, γ-PGA-Pr, and γ-PGA-Bn, respectively) was added drop-
wise to the mixture in a 5x molar excess over 5 min. The mixture was stirred at 60°C for
a period of 40 h. The reaction was quenched by removing the round bottom flask from
the oil bath, cooling to room temperature and stirring stopped.
For degree of esterification calculation, 3 mL of esterified γ-PGA/NMP solution was
precipitated in 30 mL cold HCl (pH 1.5), centrifuged at 4000 R.P.M. for 5 min, super-
natant removed, and 30 mL HCl added. This was subsequently repeated twice using
diH2O, and twice with diethyl ether (Et2O). The resulting polymer was dissolved in 600
µL DMSO-d6 for 1H-NMR, and the degree of esterification was calculated from integra-
tion of the NH peak of modified γ-PGA against that of γ-PGA-H (if present) from the
1H-NMR spectra.
If an esterification reaction level was below 100%, the reaction was returned to 60°C,
stirring. Once the solution reached 60°C, 2 molar equivalents of the required bromide was
added drop wise and allowed to react for 24 h, quenched, another withdrawal for NMR
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purified and the level of esterification analysed. This was repeated until either complete
esterification was achieved or no change in esterification level was seen with addition of
bromide.
Following confirmation of reaction esterification by 1H-NMR, the mixture containing
the reacted γ-PGA (in NMP) was decanted and the supernatant was poured into a 2 L
beaker containing 1.8 L of cold HCl (pH 1.5) and left to precipitate overnight at 4°C. The
remaining salts (NaHCO3 and NaBr) were discarded. The precipitate was filtered on a
glass filter (Por 3), washed with cold diH2O (500 mL) and diethyl ether (500 mL), and
finally dried at 40°C overnight under vacuum.
Purification
The esterified γ-PGA was dissolved in DMSO (2% solution) by mild heating (40°C) and
stirring. The solution was then precipitated in diH2O. The solid was filtered on a frit,
repeatedly washed with H2O and Et2O, and then dried at 40°C overnight under vacuum.
2.2.2 Chemical analysis
Nuclear magnetic resonance
NMR spectra were recorded on a Bruker Biospin GmbH AV500 (operating at 500 MHz
for 1H; 125.76 MHz for 13C) using DMSO-d6 as a deuterated solvent. 1H-NMR spectra
were referenced to the residual protons in the deuterated solvent. Data are reported as
follows: chemical shifts are in ppm in the δ scale; multiplicity (s: singlet, d: doublet,
t: triplet, q: quartet, m: multiplet, bs: broad signal); integration; assignment. 13C-NMR
spectra were referenced to the solvent chemical shift.
γ-PGA acid form (γ-PGA-H): 1H-NMR δ: 1.73 (m, 1H, CH β); 1.93 (m, 1H, CH β);
2.19 (t, 2H, CH2CO); 4.13 (m, 1H, CHNH); 8.21 (d, 1H, NH). 13C-NMR δ: 27.02 (CH2
β); 31.59 (CH2CO); 51.59 (CHNH); 171.66 (COOH); 173.43 (CONH).
γ-PGA Ethyl ester (γ-PGA-Et): 1H-NMR δ: 1.18 (t, 3H, CH3CH2O); 1.77 (m, 1H,
CH β); 1.95 (m, 1H, CH β); 2.19 (t, 2H, CH2CO); 4.09 (q, 2H, CH3CH2O) 4.21 (m,
1H, CHNH); 8.17 (d, 1H, NH). 13C-NMR δ: 13.87 (CH3CH2O); 26.66 (CH2 β); 31.12
(CH2CO); 51.49 (CHNH); 60.28 (CH3CH2O); 171.37 (COO); 171.68 (CONH).
γ-PGA Propyl ester (γ-PGA-Pr): 1H-NMR δ: 0.83 (t, 3H, CH3CH2CH2O); 1.53 (q,
2H, CH3CH2CH2O); 1.75 (m, 1H, CH β); 1.94 (m, 1H, CH β); 2.19 (t, 2H, CH2CO);
3.97 (m, 2H, CH2O); 4.18 (m, 1H, CHNH); 8.13 (bs, 1H, NHCHCOOH); 8.25 (bs, 1H,
NHCHCOOPr). 13C-NMR δ: 10.11 (CH3CH2); 21.45 (CH3CH2); 26.71 (CH2 β); 31.18
(CH2CO); 51.59 (CHNH); 65.80 (CH2O); 171.47 (COO); 171.87 (CONH).
γ-PGA Benzyl ester (γ-PGA-Bn): 1H-NMR δ: 1.77 (m, 1H, CH β); 1.96 (m, 1H, CH
β); 2.20 (t, 2H, CH2CO); 4.25 (m, 1H, CHNH); 5.07 (d, 2H, OCH2Ph); 7.29 (m, 5H,
H-Ar); 8.27 (d, 1H, NH,). 13C-NMR δ: 26.63 (CH2 β); 31.19 (CH2CO); 51.66 (CHNH);
65.83 (CH2O); 127.65-135.89 (C-Ar); 171.54 (COO); 171.69 (CONH).
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Film casting
Polymer films for ATR-FTIR, wide-angle x-ray scattering, and contact angle analysis
were cast onto a PTFE-lined 6-well polystyrene culture plate from a 5% wt wt-1 solution in
1,1,1,3,3,3-hexafluoroisopropanol (HFIP). Well plates were covered loosely and solutions
allowed to evaporate for 72 h at RT.
Fourier transform infrared spectroscopy
Fourier transform infrared (ATR-FTIR) spectra were obtained with a Perkin Elmer® Spec-
trum 100 FTIR Spectrophotometer, from 500 to 4000 cm-1 using the Universal diamond
attenuated total reflectance (ATR) top-plate.
Wide-angle x-ray scattering
Wide-angle x-ray scattering (WAXS) was performed by Mr. Ryan Bayliss (Materials
Department, Imperial College) on polymer films cast on PTFE (as above) using a PAN-
alytical MPD X-ray diffractometer (Almeo, Netherlands), using a Cu Kα source with a
secondary graphite monochromator (step size = 0.03 degrees, 50 s count time per step).
Size exclusion chromatography
All measurements were performed by Dr. Thomas Schweizer (ETH) on esterified γ-PGA
using a PL-GPC 220 integrated gel permeation chromatograph/size exclusion chromato-
graph (SEC) fitted with a differential refractometer, a PL-220R viscometer, and a PL-
PD2040 light scattering detector (all Varian, Inc.; Palo Alto, CA, USA). Solutions of
esterified γ-PGA (1.5 mg mL-1 in dimethylformamide (DMF) containing 1 g L-1 LiBr)
were prepared and injected through two 10 µm PLgel MIXED-B columns connected in
series using DMF at a flow rate of 1 ml min-1 and a temperature of 45°C. Data was
analyzed using Polymer Laboratories Cirrus multi software (Varian, USA) with monodis-
perse poly(methyl methacrylate) (PMMA) solutions as reference standards. SEC of γ-
PGA-H form was performed using sodium polyacrylate standards, in phosphate buffer
(pH 7) at Smithers Rapra (UK) under EPSRC.
Thermogravimetric analysis
Dynamic thermogravimetric analysis (TGA) was performed on 5-7 mg γ-PGA poly-
mers at a scanning rate of 2 °Cmin−1 under N2 at 50 ml min-1 from 25-300°C on a
TGA/SDTA851e instrument (Mettler-Toledo, Greifensee, Switzerland), calibrated with
indium and zinc.
Differential scanning calorimetry
Glass transition (Tg), crystallisation (Tc), and melting (Tm) temperatures were determined
with a Mettler-Toledo DSC822e differential scanning calorimeter, calibrated with indium
and zinc. Samples of 5-7 mg sealed in aluminium crucibles were heated under nitrogen at
a rate of 10°C min-1 from -25°C until 10-20°C above Tm. All values reported were anal-
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ysed using Mettler-Toledo STARe-Software. Melting temperatures reported here refer to
the maximum in the endothermal peaks, while crystallisation and recrystallisation (Trc
temperatures refer to the minimum value in the exothermal peaks. The second heating on
the same sample was treated as melt crystallised, and glass transition temperatures were
measured as the midpoint change in slope of this trace.
Contact angle analysis
Static water contact angle analyses were performed on the polymer films using an Easy-
drop Drop Shape Analysis System (Kruss Surface Science, Germany).
2.3 Results and discussion
2.3.1 Nuclear magnetic resonance
It is possible to identify the chemical structure of the polymer and to calculate the degree
of modification achieved during synthesis from the 1H-NMR spectra.
Table 2.1: Degree of esterification as synthesised and calculated from NH peak in 1H-
NMR.
Polymer Batch Degree of esterification/% Total reaction time/h
γ-PGA-Et 1 100 40
2 100 40
γ-PGA-Pr 1 96 110
2 94 80
3 93 80
4 100 60*
5 100 60*
γ-PGA-Bn 1 99 40
2 96 40
∗Fresh bottle of PrBr used with these synthesis batches
Modification of γ-PGA was achieved using three different bromides. Depending on the
bromide used, the total reaction time was found to be between 40 and 110 h. Esterifica-
tions using ethyl or benzyl bromide were more successful than that with propyl bromide.
Neither γ-PGA-Et nor γ-PGA-Bn required reheating with additional bromide after 40 h
of reacting. Across all polymer types, overall yield was found to be between 60-70%.
It was observed that the propyl-esterification of γ-PGA had variable reaction times. Un-
like γ-PGA-Et, after 40 h of reacting, not a single batch of γ-PGA-Pr was fully modified.
This resulted in subsequent reheating and additional reaction time to increase the esterifi-
cation. The first synthesis of γ-PGA-Pr was repeated 3 additional times for a total reaction
time of 110 h. The degree of esterification did not improve from 96% between the second
and third repeat so the reaction was stopped and purified. This was also seen between the
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first and second repeated synthesis of γ-PGA-Pr-2 (94%) and γ-PGA-Pr-3 (93%), thus the
reaction was stopped after a total time of 80 h. These two batches can be considered to be
slightly different from a fully esterified polymer (eg. γ-PGA-Pr-4 and γ-PGA-Pr-5) as the
estimated degree of esterification exceeds the error of 1H-NMR integration. The degree
of esterification for γ-PGA-Bn batches vary slightly, however they are within the error of
1H-NMR integration (γ-PGA-Bn-1 = 99% and γ-PGA-Bn-2 = 96%).
There are a few limitations of the synthesis and repeatability using this setup. Despite
literature stating NMP is the best organic solvent for γ-PGA-H with this reaction, the so-
lution must first be heated to 80°C to partially dissolve γ-PGA-H. Therefore, this varies
the actual concentration of starting polymer in solution from batch to batch. While this
may adversely affect the reaction reproducibility, γ-PGA-Et polymers were fully esteri-
fied, and γ-PGA-Bn within the error of integration, after 40 h of reacting.
Furthermore, the stirrer/hotplate was set to maintain a reaction temperature of 60°C, yet
did not have a feedback system to regulate and heat or cool accordingly. Thus, both the
oil bath and reaction were liable to environmental variations in temperature associated
with a daily reduction in the laboratory’s central heating between 11 PM and 7 AM.
It would be advantageous to perform synthesis using a temperature regulated, feedback
hotplate/stirrer system to compare any batch variability or effect on overall reaction yield.
Figure 2.1: Esterification of γ-PGA using ethyl, propyl, or benzyl bromide to produce
γ-PGA-Et, γ-PGA-Pr, and γ-PGA-Bn, respectively.
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Figure 2.2: A)1H-NMR and B) 13C-NMR spectra for unmodified γ-PGA-H polymer
(DMSO-d6, 25°C).
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Figure 2.3: A)1H-NMR and B) 13C-NMR spectra for γ-PGA-Et series polymers (DMSO-
d6, 25°C).
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Figure 2.4: A)1H-NMR and B) 13C-NMR spectra for γ-PGA-Pr series polymers (DMSO-
d6, 25°C).
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Figure 2.5: A)1H-NMR and B) 13C-NMR spectra for γ-PGA-Bn series polymers (DMSO-
d6, 25°C).
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2.3.2 Fourier transform infrared spectroscopy
The chemical structure of produced polymers was further confirmed with ATR-FTIR.
These spectra are presented in Figures 2.6-2.9. The characteristic bands of interest were
identified [25,26] for these polymers and are detailed in Table 2.2.
Figure 2.6: Fourier transform infrared spectra of native γ-PGA-H.
As seen in Figure 2.6, there are two peaks in the region of absorption frequencies of
single bonds to hydrogen spanning ν ≈ 3600-3200 cm. Two peaks of interest, an -OH
peak at 3635 cm-1 and an acid (-COOH) peak at 3550 cm-1, are shadowed in the broad
peak from ν ≈ 3600-3200 cm-1 (H-bonded -OH). These peaks confirm the native γ-PGA-
H structure is in the acid form, and there is a large amount of hydrogen bonding between
polymer chains. The disappearance of this peak with esterification is visible in Figures
2.7, 2.8, and 2.9. Characteristic peaks are shown for all polymer species with those of
the -CONH- displaying a shifted weak absorption in ν ≈ 3460-3400 cm-1 range due to the
solid state of the polymers. The amide I and amide II bands are sharply visible between
1680-1630 and 1570-1515 cm-1. Finally, the C=O band at ν ≈ 1850-1650 is very strong
in all polymers.
Introduction of an alkyl group on the side chains via esterification for γ-PGA-Et and
γ-PGA-Pr is visible between ν ≈ 2960-2850 cm-1. The additional carbon alkyl group in γ-
PGA-Pr is visible with another shoulder appearing in this range of the γ-PGA-Pr spectra
(Figure 2.8) when compared with that of the γ-PGA-Et (Figure 2.7). Other absorption is
seen with a sharp peak visible between ν ≈ 1750-1735 cm-1. Lower than this, the esterified
alkyl groups are indistinguishable from those in the native polymer chain.
The aryl group of γ-PGA-Bn is visible with a weak absorption from 3040-3010 cm-1
(Figure 2.9). The other absorption band from 1225-950 cm-1 is difficult to resolve as it
conflicts with other groups in the native polymer structure, including the side group ester
(C-O) and alkyl groups (-CH2-) on the polymer backbone.
These infrared spectra for all the polymers further confirm their chemical structure,
as was shown with 1H-NMR and 13C-NMR in the previous section. Additionally, the
disappearance of the broad peak from 3600-3200 cm-1 is consistent with NMR data of
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esterified batches.
Figure 2.7: Fourier transform infrared spectra of the synthesised γ-PGA-Et series.
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Figure 2.8: Fourier transform infrared spectra of the synthesised γ-PGA-Pr series.
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Figure 2.9: Fourier transform infrared spectra of the synthesised γ-PGA-Bn series.
58
2.3 Results and discussion
Table 2.2: Fourier transform infrared spectra absorptions and chemical groups of interest
for native γ-PGA and esterified polymers. Table generated from values listed in [25,26]
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2.3.3 Wide-angle x-ray scattering
Wide-angle x-ray scattering (WAXS) was performed on cast films of γ-PGA-H and mod-
ified γ-PGA polymers, confirming semicrystalline structures. WAXS spectra are plotted
by modified polymer series in Figures 2.10-2.12 and are plotted together with γ-PGA-H
in Figure 2.13.
Interatomic distances are presented in Table 2.3, as calculated using Bragg’s law (Equa-
tion 2.1) where n is the layer line (1 for these calculations), λ is the wavelength of the
x-ray source (λ Cu Kα = 1.54439 Å), d represents the interatomic spacing in Å and θ is
the scattering angle (°).
nλ = 2dsinθ (2.1)
Both γ-PGA-Et (Figure 2.10) and γ-PGA-Pr (Figure 2.11) polymer series express some
degree of order, shown with two peaks, a slight 200 peak at 8-9° and the more intense 011
peak at 20-21°, corresponding to approximately 10-11 Å and 4.2 Å, respectively. The
γ-PGA-Bn (Figure 2.12) series displayed a broader 011 peak than the alkyl-esterified γ-
PGA polymers, shifted to lower 2θ values and thus higher interatomic distances. The
weak 200 peak was found around 11-12 Å while a broader 011 peak showed some order
around 4.5-4.6 Å. This broadening of this 011 peak, when compared to that of γ-PGA-Et
and γ-PGA-Pr, indicates the benzyl experiences less order.
Similarly, the γ-PGA-H (Figure 2.13) displayed a very broad 011 peak, slightly shifted
to 22° with a d-spacing of 4.03 Å. Several sharp peaks were seen in the γ-PGA-H diffrac-
tion, and these are peaks from NaCl, an expected byproduct from the acidification of
γ-PGA-Na+ using HCl.
The results shown here indicate the γ-PGA-H polymer may be mostly amorphous,
while all esterified polymers are semicrystalline. This will be investigated using differen-
tial scanning calorimetry in the following section, and discussed further in Section 5.4.5.
60
2.3 Results and discussion
Figure 2.10: Wide-angle x-ray scattering pattern of the synthesised γ-PGA-Et series.
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Figure 2.11: Wide-angle x-ray scattering pattern of the synthesised γ-PGA-Pr series.
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Figure 2.12: Wide-angle x-ray scattering pattern of the synthesised γ-PGA-Bn series.
Table 2.3: Distances between similar atomic planes for batches of γ-PGA polymers.
Polymer Synthesis (200) (011)
d / Å 2θ⇑° d / Å 2θ/ °
γ-PGA-H - - - 4.03 22.11
γ-PGA-Et 1 9.94 8.91 4.23 21.04
2 10.33 8.58 4.28 20.81
γ-PGA-Pr 1 10.15 8.72 4.24 20.72
2 10.31 8.59 4.27 20.86
3 10.87 8.15 4.25 20.96
4 9.64 9.19 4.26 20.89
5 10.81 8.15 4.23 21.06
γ-PGA-Bn 1 11.83 7.49 4.64 19.15
2 12.62 7.02 4.49 19.79
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Figure 2.13: Wide-angle x-ray scattering pattern of the all γ-PGA-polymers plotted to-
gether.
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2.3.4 Size exclusion chromatography
The molecular weight distributions of the starting and modified γ-PGAs were determined
using size exclusion chromatography. All esterified γ-PGA polymer results are relative to
PMMA standards (in DMF with 1g/L LiBr) while that of γ-PGA-H is relative to sodium
polyacrylate (in phosphate buffer, pH 7). The starting γ-PGA-H polymer, as produced by
Bacillus subtilis, has a high weight-average molecular weight (Mw) of 2.83 x 105, with a
fairly broad distribution as shown in its’ polydispersity index (PDI, 2.40).
Esterification of γ-PGA caused a slight decrease in molecular weight of polymers, but
this was maintained above 105 kDa for all batches except γ-PGA-Bn-1 (8.67 x 104). A
variation in molecular weight distribution and PDI was observed across the synthesis
batches, as seen in Table 2.2. Longer reaction times resulted in a lower average Mw and
higher PDI for some polymer batches (notably γ-PGA-Pr-1 and γ-PGA-Pr-4), though this
was not uniform for the entire series.
The SEC for γ-PGA-H was performed in an aqueous solvent as they were not soluble
in organic solvents like modified γ-PGAs. Therefore, the Mw of γ-PGA-H is 2.83 x 105,
relative to sodium polyacrylate. While the specific results cannot be directly compared
between the different conditions, they provide an order of magnitude estimate about the
polymers’ weight-average molecular weights.
Table 2.4: SEC results for differing batches of γ-PGA esterifications.
Polymer Synthesis Mn/g mol-1 Mw/g mol-1 P.D.I. Total reaction time/h
γ-PGA-H∗ - 1.18 x 105 2.83 x 105 2.40 -
γ-PGA-Et 1 6.16 x 104 1.40 x 105 2.28 40
2 6.31 x 104 1.38 x 105 2.18 40
γ-PGA-Pr 1 3.93 x 104 1.62 x 105 4.12 110
2 8.30 x 104 1.99 x 105 2.39 80
3 1.03 x 105 2.69 x 105 2.62 80
4 5.35 x 104 1.62 x 105 3.02 60
5 8.01 x 104 1.81 x 105 2.26 60
γ-PGA-Bn 1 3.24 x 104 8.67 x 104 2.67 40
2 5.08 x 104 1.46 x 105 2.88 40
∗SEC performed in aqueous solvents by Smithers Rapra
2.3.5 Thermogravimetric analysis
Dynamic thermogravimetric analyses (TGA) were performed on all polymers to deter-
mine temperatures of thermal degradation. The temperatures at which polymers experi-
enced 5% decomposition is presented in Table 2.5. The native γ-PGA-H form experiences
decomposition early at 165°C, though a gradual weight loss is seen at from slightly lower
temperatures. All the esterified polymers experience degradation at much higher temper-
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atures (> 230°C).
Table 2.5: Thermogravimetric analysis of esterified γ-PGA polymers.
Polymer Synthesis 5% Decomposition/°C
γ-PGA-H - 165
γ-PGA-Et 1 244
2 242
γ-PGA-Pr 1 235
2 231
3 231
4 243
5 245
γ-PGA-Bn 1 245
2 236
Esterification improves heat stability of γ-PGA, up to 245°C. This is likely due to the
degradation mechanism of the native γ-PGA polymer. Assuming the polymer undergoes
the proposed degradation mechanism as published by Melis et. al, [159], a five-membered
ring is formed from an intramolecular nucleophilic attack of the NH onto the CO ester
carbon at the chain end. Introduction of a side group leads to a higher Mw of the monomer,
requiring more energy to volatilise and thus increasing the onset of thermal degradation.
2.3.6 Differential scanning calorimetry
Differential scanning calorimetry (DSC) was employed to determine the transition tem-
peratures of the polymers. DSC was performed on purified powders and the heating/cooling
rates were kept at 10°C min−1. All heating traces of esterified polymers are presented in
Figures 2.14-2.16 and the results tabulated in Table 2.6.
As the γ-PGA used here is purchased in the Na+ form (γ-PGA-Na+) and then acid-
ified (yielding γ-PGA-H) prior to esterification, DSC was performed on both polymers
to investigate their respective Tg and Tm. These values are presented in Table 2.6. The
γ-PGA-Na + had a Tg of 93°C while that of γ-PGA-H was found to be 124°C. This in-
crease in Tg is attributed to the nature of the side chain. At neutral pH, the -O− is charge
balanced by the Na+ ion, but at acidic pH below the pKa (pH = 4.0), the oxygen is sat-
urated (- OH). This introduces hydrogen bonding between polymer chains, resulting in
restriction of bond rotation and a higher Tg.
The DSC analyses indicate that esterification of γ-PGA results in a much lower Tg than
γ-PGA-H, as shown in Table 2.6. Introduction of the esterified group reduces hydrogen
bonding between polar -OH groups and allows more chain mobility at lower temperatures.
Glass transition temperatures were found to be relatively consistent among batches of
γ-PGA-Et and γ-PGA-Bn, while γ-PGA-Pr batch Tg values range from 23-47°C. This
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range may be attributed to degradation experienced in the first heating, as both batches
experienced 5% degradation at 231°C. A lower degree of esterification, and thus less
chain regularity, also contributes to a lower Tg than that of fully modified batches.
Interestingly, however, γ-PGA-Bn did not display a much higher Tg than alkyl esterified
batches. The presence of bulky side groups, such as the benzyl group, disrupt hydrogen
bonding. This may interfere with chain packing which increases the amorphous volume
fraction, and result in a restriction of bond rotation [160,161], effectively increasing Tg more
than flexible side groups like the two short alkyl groups used in this study. Thus it is
hypothesised the Tg may be due to the level of esterification being 99% and 96% (as
determined by 1H-NMR for γ-PGA-Bn-1 and γ-PGA-Bn-2 respectively).
Upon the first heating, only γ-PGA-Pr polymers experienced recrystallisation. All γ-
PGA-Et and γ-PGA-Pr polymers displayed a sharp melting peak while γ-PGA-Bn either
had a double melting peak (γ-PGA-Bn-1) or a shoulder peak (γ-PGA-Bn-2). Tm was
found to increase with decreasing size of the esterified group. γ-PGA-Bn polymers had
the lowest value of Tm, which may be attributed its’ side group introducing disruptions
into the polymer crystals [102].
All polymers experienced degradation with melting. This was more prominent in γ-
PGA-Pr batches, notably γ-PGA-Pr-2. Degradation during the first heat resulted in a
change upon the second heat, as shown in the plotted DSC curves (2.14-2.16) and the
values tabulated in Table 2.6. This degradation had a destructive effect on γ-PGA-Et and
γ-PGA-Pr polymers, which have a 5% Td near or below their respective Tm. Upon the
second heating, melting peaks appeared slightly rounded, less intense and had a lower
melting peak temperature. In particular, γ-PGA-Pr-2 was significantly affected, as seen in
the second heating. This effect was less prominent with γ-PGA-Bn polymers, as the Tm
lies 15-20°C below the 5% Td.
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Figure 2.14: DSC heating traces of synthesised γ-PGA-Et series, where black indicates
first heating and red is the second.
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Figure 2.15: DSC heating traces of synthesised γ-PGA-Pr series, where black indicates
first heating and red is the second.
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Figure 2.16: DSC heating traces of synthesised γ-PGA-Bn series, where black indicates
first heating and red is the second.
Table 2.6: Thermal results for all γ-PGA polymers obtained via DSC, where Trc is mea-
sured during heating and Tc from cooling.
Polymer Synthesis Tg ⇑°C Trc ⇑°C Tc ⇑°C Tm 1 ⇑°C Tm 2 ⇑°C
γ-PGA-Na+ - 93 - - 203 -
γ-PGA-H - 124 - - - -
γ-PGA-Et 1 48 - 177 251 232
2 49 - 180 251 234
γ-PGA-Pr 1 44 174 170 231 224
2 23 181 147 233 217
3 31 181 152 235 221
4 43 178 172 237 228
5 47 177 182 239 232
γ-PGA-Bn 1 55 - 163 224 217
2 50 - 156 221 212
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Table 2.7: Thermal results for all γ-PGA polymers obtained via DSC in K.
Polymer Synthesis Tg /K Tm 1 /K Tg/Tm
γ-PGA-Na + 366 476 0.77
γ-PGA-H 397
γ-PGA-Et 1 321 524 0.61
2 322 524 0.61
γ-PGA-Pr 1 317 504 0.63
2 296 506 0.58
3 304 508 0.60
4 316 510 0.62
5 320 512 0.63
γ-PGA-Bn 1 328 497 0.66
2 323 494 0.65
When presented in Kelvin, the value of Tg is generally between 0.5 and 0.8 Tm [102],
thus showing the strong relationship between the Tg and Tm. The results obtained from
the modified γ-PGA polymers are tabulated in Table 2.7 and plotted in Figure 2.17
Figure 2.17: Plot of Tm as a function of Tg for γ-PGA-Na+ and modified γ-PGA polymers.
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2.3.7 Contact angle
Finally, water contact analysis was performed to examine the hydrophobicity of the vari-
ous γ-PGAs. The measurement was conducted with t = 0, 1 min, as it was observed that
a water droplet became stable after this period of time. Expectedly, water contact angle
(WCA) measurements show that the esterified γ-PGAs are more hydrophobic than the
unsubstituted γ-PGA-H, with γ-PGA-Bn displaying a contact angle higher than γ-PGA-
Et and γ-PGA-Pr (Figure 2.18). Data for all polymers are deemed statistically significant
both from the two time scales and between each polymer species, with the exception
of γ-PGA-Bn and poly(L-lactic acid; PLLA)(p < 0.001; Two-way ANOVA with Tukey
post-hoc test).
As noted above, the contact angle increased with increasing hydrophobicity of the side
group. Interestingly, the highest contact angle, that of γ-PGA-Bn, is similar to that of the
highly-characterised, FDA-approved PLLA, which is widely used in tissue engineering.
Figure 2.18: Contact angle analysis for for as-cast, dried γ-PGA films compared to
PLLA(* p < 0.001, n.s. = not significant).
2.4 Conclusions
In this chapter, the water solubility of γ-PGA was diminished by esterification with alkyl
or aryl groups, enabling the polymer for use in tissue engineering applications. Full mod-
ification of the γ-PGA-H was achieved using either ethyl bromide or benzyl bromide,
while >90% modification was possible using propyl bromide with an approximate yield
of 60-70% for all polymers. Polymers were fully characterised for their chemical, struc-
tural, and thermal properties. All produced polymers were found to be semicrystalline and
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synthesis resulted in a relatively polydisperse polymer (PDI 2-3, with one batch having a
PDI of 4.12), yet molecular weights were maintained above 105 kDa for all but one batch.
Esterification led to a decrease in glass transition temperature while the the degradation
temperature increased, widening the thermal processing window for all polymers.
The synthesis would benefit from scaling up, as each batch produces roughly 1.6 grams
of material and batch-to-batch variation inhibits combining multiple syntheses for one ap-
plication. Variability between batches is attributed to the experimental equipment, which
may be improved by using a temperature-regulated feedback system with future synthe-
ses.
Esterification of the non-toxic, enzymatically degradable γ-PGA-H expectedly shielded
of the H-bonds present in the unmodified form, rendering the polymer water insoluble in
powder form. Furthermore, the water contact angle increased with increasing hydropho-
bicity of the side chain. The fully esterified γ-PGA polymers, would be excellent can-
didates for tissue engineering. Thus it is of particular interest for this thesis to focus on
utilising these polymers to investigate their mechanical properties and biocompatibility.
Given the high Mw maintained in the esterification, it would be useful to utilise techniques
to tailor the mechanical properties to target specific tissues, which is the main focus of the
next chapter.
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Chapter 3
Modification of γ-PGA with Phenylala-
nine
3.1 Introduction
This chapter investigates chemical modification of poly (gamma-glutamic acid; γ-PGA)
using an amino acid both as an alternative method to esterification for decreasing γ-PGA
water solubility and as a strategy to increase functionality of the polymer. In the previous
chapters, γ-PGA was esterified using alkyl or aryl groups. Esterification with benzyl bro-
mide displayed the most promise, and was focused on with cell and dissolution studies. It
has been shown in Chapter 6 that this synthesis may be scaled to produce larger quantities
with higher yields by modifying the experimental setup.
A main focus of this thesis is modifying the -COOH side group in γ-PGA, which pro-
vides a site for functionalisation of the polymer, as discussed previously in Section 1.4
and Chapter 2. Instead of creating an ester bond which may be liable to random hydroly-
sis, the synthesis within this chapter focuses on coupling a modified phenylalanine to the
side chain using a carbodiimide coupling agent. The side group of phenylalanine has an
aromatic ring, which should help to provide water resistance to the γ-PGA-H like that of
the benzyl group in γ-PGA-Bn. It is anticipated that the phenylalanine-modified polymer
may be more stable over time as the peptide bond will be less liable to hydrolysis than an
ester. Furthermore, modification with an amino acid paves the way for coupling peptide
sequences with specific targeting abilities, as discussed in Section 1.2.4, to γ-PGA.
To date, no work has been published on using γ-PGA-conjugated with phenylalanine
for tissue engineering applications. The Akashi group from Osaka university have re-
cently published several papers on γ-PGA partially grafted (53%) with L-phenylalanine
ethyl ester [162–170] to generate amphiphilic nanoparticles for vaccination or drug delivery.
Their work provides hydrophobicity by utilising a water soluble 1-ethyl-3-(3-dimethylami-
nopropyl) carbodiimide (WSC) to couple phenylalanine to the γ-PGA. Therefore, cou-
pling phenylalanine to γ-PGA-H should still provide the polymer with water resistance,
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making it an excellent candidate for tissue engineering applications.
This chapter presents the synthesis, chemical, and thermal properties of phenylalanine
modified γ-PGA for tissue engineering applications.
3.2 Experimental
3.2.1 Chemical synthesis
General
All starting polymer (γ-D,L-PGA Na+ salt, produced by Bacillus subtilis) was purchased
from Natto Biosciences (Shanghai, China). All reagents and solvents were purchased
from Aldrich and used as received, unless otherwise specified.
Free acid form of γ-PGA
γ-PGA Na+ salt (10 g) was dissolved in 250 mL of distilled water. The solution was
acidified with HCl 6M to pH 1.5 and lyophilized for at least 96 h. The freeze-dried solid
resulted soft and porous.
γ-PGA-H N-terminus protection
For N-terminus protection, γ-PGA free acid (+ NaCl) (2.5 g, 0.08 M) was introduced into
a 250 mL round bottom flask equipped with a magnetic stirrer, and suspended in 180 mL
of diH2O at room temperature. Once dissolved, the pH was adjusted to 4 using NaOH.
Subsequently, 0.25 molar equivalents of Boc anhydride (0.78 mL) was added dropwise,
the flask vented to allow CO2 release, and the solution left to react for 24 h at room
temperature. Upon completion, the solution was dialysed (Molecular weight cut off =
50,000 Da; SpectraPor, SpectrumLabs via VWR) against water for two days, changing
every 12 h. The dialysed solution was frozen at -80°C and lyophilized for at least 96 h,
resulting in a soft, porous solid.
One-step phenylalanine coupling
For one-step amino acid coupling four separate reactions were performed. Boc-protected
γ-PGA-H (0.5 g, 0.091 M) was suspended in 30 mL anhydrous N-Methyl Pyrrolidone
(NMP). The suspension was heated by oil bath to 60°C and stirred for 24 h. Meanwhile,
1.3, 2, 4, and 5 equivalents of L-Phenylalanine amide hydrochloride (Phe-CONH2; Merck
Chemicals, Nottingham, UK) were dissolved separately in 5 mL NMP and neutralised
with 1 molar equivalent (to Phe-CONH2) of N,N-diisopropylethylamine (DIPEA).
After 24 h, 1.3 molar equivalents of N,N’-dicyclohexylcarbodiimide (DCC) in NMP
(0.68 M) was added drop wise to the Boc-γ-PGA-H mixture and allowed to react for 30
min at 60°C. Following this time, the neutralised amino acid solutions were added drop
wise, NMP supplemented to make a final volume of 70 mL, and left to react for 48 h.
For degree of conversion calculations, 3 mL of the solution was precipitated over ice
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in a 1:1 mixture of acetone and diethyl ether, as the solution did not precipitate in cold
HCl (pH 1.5). This was centrifuged at 4000 R.P.M. for 5 min, supernatant removed,
30 mL cold diethyl ether added, and repeated four times. The resulting polymer was
dissolved in 400 µL DMSO-d6 for 1H-NMR, and the degree of coupling was calculated
from integration of the NH peak of modified γ-PGA against that of γ-PGA-H from the
1H-NMR spectra.
Two-step phenylalanine coupling
In another approach to the amino acid coupling, Boc-protected γ-PGA-H (128 mg) was
suspended in a 3:1 mixture of PBS:NMP. Solutions of EDC:NHS (1:2 molar equivalents
of polymer) in PBS and 11.7 molar equivalents of Phe-CONH2 in 3:1 PBS:NMP were
added drop wise to the stirring polymer suspension for a final volume of 28 mL, and
allowed to react at room temperature. After 48 h, the solution was transferred to dialysis
tubes (as before) and dialysed against water for 48 h, changing every 12 h. Following
dialysis, the product was frozen and lyophilized for 96 h, yielding 150 mg porous solid
product. Finally, 10 mg of the partially modified, lyophilized polymer was dissolved in
500 µL DMSO-d6 and 1H-NMR confirmed the product was approximately 30% coupled.
For the second coupling step, the polymer produced from the previous step was dis-
solved (150 mg, 0.04M) in 25 mL NMP. Meanwhile, 1.3, and 5 molar equivalents of
DCC and Phe-CONH2 (neutralised 1:1 with DIPEA), respectively, were dissolved sepa-
rately in NMP. The DCC solution was added, and after 30 min the neutralised Phe added
drop wise and allowed to react. After 48 h, the solution was transferred to dialysis bags
as before and dialysed against water for 72 h, changing every 12 h.
Two-step phenylalanine coupling purification
Polymer precipitated by dialysis was centrifuged at 4000 R.P.M., the supernatant re-
moved, and washed repeatedly with cold HCl (pH 1.5) to remove the Boc protecting
group. This was followed by repeated washes with H2O and finally diethyl ether. The
product retrieved was redissolved in DMSO (2% w/v), filtered through cotton, precip-
itated into cold HCl, and centrifuged. The polymer was then repeatedly washed with
sonication in methanol and subsequently washed in diethyl ether before drying at 40°C.
Finally, 10 mg of produced polymer was dissolved in 500 µL DMSO-d6 and 1H-NMR
performed.
3.2.2 Chemical analysis
Nuclear magnetic resonance
NMR spectra were recorded on a Bruker Biospin GmbH AV500 (operating at 500 MHz
for 1H; 125.76 MHz for 13C) using DMSO-d6 as a deuterated solvent. 1H-NMR spectra
were referenced to the residual protons in the deuterated solvent. Data are reported as
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follows: chemical shifts are in ppm in the δ scale; multiplicity (s: singlet, d: doublet,
t: triplet, q: quartet, m: multiplet, bs: broad signal); integration; assignment. 13C-NMR
spectra were referenced to the solvent chemical shift.
Phenylalanine coupled γ-PGA (γ-PGA-Phe): 1H-NMR δ: 1.75 (m, 1H, CH β [back-
bone]); 1.91 (m, 1H, CH β [backbone]); 2.07 (t, 2H, CH2CO); 2.72 (m, 1H, CH β [side
chain]); 3.08 (m, 1H, CH β [side chain]); 4.07 (m, 1H, CHNH [backbone]); 4.39 (m, 1H,
CHNH [side chain]); 7.19 (m, 5H, H-Ar); 7.42 (d, 1H, NH [side chain]); 7.85 (m, 1H,
NH β [side chain]); 7.94 (m, 1H, NH β [side chain]); 8.23 (d, 1H, NH [backbone]).
13C-NMR δ: 27.75 (CH2 β [backbone]); 31.50 (CH2CO); 37.24 (CH2 β [side chain]);
52.87 (CHNH [backbone]); 53.87 (CHNH [side chain]); 126.30-137.97 (C-Ar); 171.22
(CONH2); 171.74 (CH2CONH); 173.00 (CHCONH).
3.2.3 Thermal analysis
γ-PGA-Phe produced was thermally characterised as previously stated in Chapter 2 using
TGA and DSC. The glass transition temperature (Tg) was measured from the second run
in a program of heating to 120°C, cooling to -25°C, and heating to 245°C, all at 10°C
min.
3.3 Results and discussion
3.3.1 One-step γ-PGA-Phe coupling
To couple the phenylalanine to γ-PGA, a one-step reaction was attempted to limit purifi-
cation steps and overall synthesis time. However, it was found that if the cloudy reaction
of Boc-γ-PGA-H in NMP was cooled to room temperature, the polymer crashed out of so-
lution prior to adding the carbodiimide (DCC). After addition of DCC and the neutralised
phenylalanine, the cloudy solution became more transparent over time as the degree of
coupling increased.
NMR withdrawals for all four reactions of one-step γ-PGA-Phe coupling in NMP were
unable to be precipitated in cold HCl (pH 1.5), which was the method used for fully
esterified γ-PGA polymers. Instead, a cold 1:1 mixture of acetone:diethyl ether was em-
ployed for purification of the polymer. Figure 3.1 displays the most pure NMR spectrum
of the four obtained for the coupling reactions. Very little product was able to be retrieved
through repeated washing, resulting in low intensity of the polymer peaks, as shown in
Figure 3.1. Also visible in Figure 3.1 are numerous impurities, shown by the number of
peaks, whose signal intensity overpowers that of the polymer.
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Figure 3.1: 1H-NMR for retrieved γ-PGA-Phe polymer coupled using DCC and 5 molar
equivalents of phenylalanine.
None of the four reactions performed were able to be modified above 30% using this
one-step synthesis in NMP, as determined by 1H-NMR. This is speculated to be caused
by the initial poor solubility of Boc-γ-PGA-H in NMP. Furthermore, the cloudy reaction
indicates that the actual polymer concentration in solution is unknown.
It is anticipated that performing this coupling in two steps may be better for obtaining
100% modification. Partially modifying the Boc-γ-PGA-H using EDC/NHS chemistry in
an aqueous/organic solvent mix first may help with Boc-γ-PGA-H solubility. The mixture
of solvents will solubilise the un- and partially modified polymer in the aqueous and
organic phase, respectively. Following purification of this, an organic solvent should
dissolve the partially modified starting polymer, allowing a more reliable calculation of
polymer concentration in the solution.
3.3.2 Two-step γ-PGA-Phe coupling
By performing the synthesis in two separate steps, full coupling of phenylalanine to
Boc-γ-PGA-H was achieved. The first step, performed in a mixture of PBS/NMP using
EDC/NHS chemistry, resulted in approximately 30% coupling according to 1H-NMR.
This product was then purified from the water-soluble urea byproducts via dialysis and
lyophilized for preparation of the second synthesis step.
Once partially modified, the Boc-[γ-PGA-Phe]m-[γ-PGA-H]n polymer readily dissolved
in NMP. The reaction was transparent, unlike the cloudy solution of Boc-γ-PGA-H in
NMP. By improving the initial solubility in NMP from the partial modification step, the
polymer concentration in NMP is more accurately determined and may help with repro-
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ducibility of the reaction. This time using DCC, a highly efficient coupling reagent, a
large excess of phenylalanine was used to push the reaction to full modification.
Upon completion of the second synthesis step, 1H-NMR confirmed that 100% cou-
pling of phenylalanine had been accomplished. Unfortunately, the NMR spectra also dis-
played numerous impurities, mainly attributed to a synthesis byproduct, dicyclohexylurea
(DCU), as highlighted in Figure 3.2.
A relatively pure, 100% coupled product was obtained from the two-step synthesis
after repeated washing. Using NMR techniques including 13C-DEPT 135 and 13C-COSY
NMR, the new, relevant peaks from the phenylalanine were identified for this polymer. All
NMR spectra obtained from the two-step coupling are presented in the following section.
3.3.3 Nuclear magnetic resonance
As anticipated, one byproduct of the DCC coupling reaction is DCU, a compound that
is only soluble in a few alcohols or chloroform. Once fully modified, the γ-PGA-Phe
also is slightly soluble in these solvents, thus removing DCU is difficult. Following filtra-
tion through cotton, purification washing steps were repeated for a total of three cycles,
performing NMR analysis after each ”wash”. With each cycle, the spectral intensity de-
creased for impurities, as shown in Figure 3.2.
Figure 3.2: 1H-NMR for fully coupled γ-PGA-Phe polymer, where impurities (DCU)
indicated in red diminish with repeated wash steps.
1H- and 13C-NMR were used to determine the chemical structure of the γ-PGA-Phe
polymer, as shown in Figure 3.3. This was further distinguished using 13C- DEPT NMR,
which shows CH and CH3 pulse intensities as positive, while those of CH2 are negative
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(Figure 3.4). The 1H- 13C- COSY NMR correlation spectrum was also elucidated by
interpreting the identification of protons with their corresponding carbon atoms in the
structure (Figure 3.5).
Figure 3.3: A) 1H-NMR and B) 13C-NMR for fully coupled γ-PGA-Phe polymer. Side
group peaks are labeled in red lettering while peaks from impurities are indicated with
black ”x” symbols.
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3.3.4 13C- DEPT NMR
Figure 3.4: 13C- DEPT 135 NMR for fully coupled γ-PGA-Phe polymer.
3.3.5 1H-13C- COSY NMR
Figure 3.5: 1H-13C-COSY NMR for fully coupled γ-PGA-Phe polymer.
3.3.6 Thermal analysis
Dynamic TGA was performed on γ-PGA-Phe to the determine the temperature at which
the polymer experienced 5% decomposition. DSC was then employed to determine the
transition temperatures of the polymers. Performed on the purified powder, the DSC
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heating/cooling rate was kept at 10°C min−1. Both heating traces of esterified polymers
are presented in Figure 3.6 and thermal results are tabulated in Table 3.1. In order to
obtain the Tg, a shortened heating run was performed from -25°C to 120 °C, cooled to
-25°C, and then the Tg was measured as before from the full heating run of -25°C to
245°C.
Figure 3.6: First and second heating DSC traces for fully coupled γ-PGA-Phe polymer,
with excess solvent visible in the first heating, thus a separate, pre-heat run was performed
to 120°C for the second heating trace to remove excess solvent for accurate Tg calculation.
Table 3.1: Thermal characterisation of coupled γ-PGA-Phe.
Synthesis Tg /°C Tm /°C 5% Td /°C
γ-PGA-Phe 156 not visible 255
Though two peaks were visible in the first heating trace, no melting or recrystallisation
was seen on the DSC traces for coupled γ-PGA-Phe. These endothermic peaks are thought
to be a result of residual solvent evaporation. This polymer was found to have a very high
glass transition temperature (156°C), which is most likely due to the chemical nature
of the side chain. The additional amine and CONH2 groups encourage more hydrogen
bonding between chains than the native γ-PGA-H, restricting motion even further and
increasing the Tg.
The glass transition temperatures and mechanical properties of γ-PGA-H and γ-PGA-
Bn polymers shown in Chapter 5 are presented in Table 3.2. γ-PGA-H was found to be
very brittle at room temperature, with a modulus of 4.7 GPa, tensile strength of 94 MPa,
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and strain at break of 2%. This was attributed to two factors, the H-bonding between
chains that limits chain motion and the Tg (124°C). While these are interrelated, testing
performed at room temperature was in the glassy state of γ-PGA-H, leading to brittle
behaviour.
Table 3.2: Thermal and mechanical properties of γ-PGA polymers as presented in Chapter
5.
Polymer Tg/ °C E/ GPa σy/ MPa σ/ MPa / %
γ-PGA-H 124 4.99 - 94 2
γ-PGA-Bn 40 1.24 28.1 20.3 106
With introduction of the benzyl ester on the side chain, H-bonds between chains of
γ-PGA-H were diminished. This allowed for more chain motion, and the bulky benzyl
side group may have created more void volume, leading to a large drop in Tg. When
testing at room temperature, γ-PGA-Bn was found to be ductile, breaking at 106%, with
a decreased modulus and tensile strength when compared with the brittle γ-PGA-H (1.24
GPa and 28.1 MPa, respectively).
By comparing the relationship of thermal and mechanical properties of γ-PGA-H and
γ-PGA-Bn, the produced γ-PGA-Phe, with a high Tg of 156°C, should be brittle at room
temperature. The introduction of more hydrogen bonding per monomer is expected to
increase the mechanical properties, and it is speculated that γ-PGA-Phe would have a
higher modulus than that of the native γ-PGA-H polymer.
Properties of nylon 12 and nylon 6,6 are presented in Table 3.3, as reported in the
Springer Handbook of Condensed Matter and Materials Data [27]. Though both polymers
have twelve carbon atoms, one main difference between them is that nylon 6,6 has twice
as many N-H and C=O groups as nylon 12. According to [27], nylon 6,6 has a higher Tg
and yield stress than nylon 12 and is twice as stiff. This is an encouraging example for γ-
PGA-Phe, thus it would be advantageous to produce more material and perform thorough
mechanical tests.
Table 3.3: Thermal and mechanical properties of nylon polymers as presented in [27].
Polymer Tg, °C E, GPa σy, MPa
Nylon 12 50 1.3 - 1.6 45 - 60
Nylon 6,6 80 2.7 - 3.3 75 - 100
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3.4 Conclusions
This study focused on coupling an amino acid to γ-PGA-H, yielding γ-PGA-phenylalanine.
Initially a one-step synthesis was performed, yielding a polymer of approximately 30%
modification. Full modification to γ-PGA-Phe was only achieved through a two-part syn-
thesis containing urea impurities from the reaction. This may benefit from using a dif-
ferent carbodiimide coupling agent, such as N,N’-Diisopropylcarbodiimide (DIC), in the
second synthesis step that will react to form a urea which will be easier to purify from
the polymer. The chemical structure of γ-PGA-Phe was identified and confirmed using
1H-NMR, 13C-NMR, 1H-13C- COSY NMR and 13C-DEPT-135 NMR.
The polymer experienced 5% weight loss at 255°C and no melting was seen before
this temperature was reached. With introduction of an amino acid side group, the Tg
increased to 156°C, caused by more hydrogen bonding between polymer chains. The
increased number of interchain hydrogen bonds of γ-PGA-Phe means tensile deformation
would not be a possible processing method. However, it is anticipated this bonding will
increase the mechanical properties when compared with those of γ-PGA-H and γ-PGA-
Bn polymers.
This synthesis chapter highlights the ability to fully modify γ-PGA-H using an amino
acid, which opens the possibility for functionalisation of γ-PGA with other amino acids
or short peptide sequences. Various extracellular matrix protein-mimicking peptides may
be of interest for better cell incorporation in a scaffold of this material. This work helps
pave the way to targeting specific tissue engineering applications using γ-PGA polymers,
showing that γ-PGA is a versatile polymer whose functionality may be highly controlled
and tuned through chemical modification.
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Chapter 4
Cytotoxicity and culture stability of es-
terified γ-PGA
4.1 Introduction
As reviewed in Section 1.3.1, scaffolds produced for tissue engineering must fulfil as
many as possible of the characteristics listed in Table 1.2, most notably biocompatibility
and biodegradability. Previously discussed in Section 1.3.2, non-toxic, naturally produced
γ-PGA is an excellent candidate for tissue engineering. In the preceding two chapters, γ-
PGA was esterified to reduce the water solubility. There is a distinct lack of publications
on the biocompatibility of esterified γ-PGA. Therefore, this chapter aims to assess the
biocompatibility of these modified γ-PGA polymers.
While the native γ-PGA polymer backbone is enzymatically degraded, [134–136] the side
groups introduced to reduce the water solubility are coupled through an ester bond. Sim-
ilar to the degradation of FDA-approved polyesters like polycaprolactone and poly-L-
lactide, this bond may be subject to random hydrolysis. Released side groups, now alkyl
or aryl alcohols, may have an adverse effect on biocompatibility. Furthermore, the poly-
mer scaffold may lose water resistance, allowing dissolution of the construct and thus
a loss of mechanical properties. Therefore another focus of the work presented in this
chapter is to determine and quantify whether or not any side chain hydrolysis or overall
dissolution of the modified polymer takes place.
4.2 Experimental
All reagents for cell culture were used as purchased from Invitrogen (Paisley, UK) unless
stated otherwise. Salts were purchased from Sigma-Aldrich (Gillingham, UK), the Triton
X-100 from BDH laboratories (Poole, UK). Aluminum Scanning Electron Microscopy
(SEM) pin stubs and adhesive carbon discs were purchased from Agar Scientific (Stand-
sted, UK).
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4.2.1 ISO 10993:5 pre-clinical cytotoxicity test
Modified γ-PGA films were sterilised for 2 h on each side under UV light and prepared
with a material surface area to culture medium ratio of 6 cm2 mL-1 according to thin-
film requirements outlined in ISO10993:12. Similarly, controls were calculated with an
extraction ratio of 3 cm2 mL-1 [negative, non-toxic PVC (Med7539 noDop) tubing; pos-
itive, organo-tin stabilised PVC sheet, t > 0.5 mm; both kindly supplied by Raumedic
(Munchberg, Germany)] and sterilised using 70% ethanol for 40 min and allowed to air
dry.
The mouse osteoblast cell line MC3T3-E1 (European Collection of Cell Cultures; Sal-
isbury, U.K.) was routinely cultured under standard conditions (37°C, 5% CO2, 100%
humidity) in Alpha Minimum Essential Medium (α-MEM) supplemented with 10% (v/v)
foetal bovine serum (FBS) and 2 mM L-glutamine (all Invitrogen; Paisley, U.K.).
Sterile samples were soaked in α-MEM for 7 days at 37°C, 5% CO2 to make the con-
ditioned media. MC3T3-E1 cells were seeded into 96 well plates at a density of 20,000
cells cm-2 in standard culture medium (as above). Cells were imaged on an Olympus IX51
epifluorescence microscope fitted with a DP-70 camera (London, U.K.). After 24 h, the
medium was exchanged with conditioned culture medium (supplemented with 10% v/v
FBS and 1% v/v L-glutamine) and diluted by factors of 2, 4, 8, or 16 with standard cul-
ture medium for 24 h, upon which the cellular metabolic activity was assessed using MTT
(3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide). For the assay, 20 µL of
a sterile-filtered 5 mg mL−1 solution of MTT in Dulbecco’s phosphate buffered saline
(DPBS, pH 7.4) was added to the culture media and incubated for 2 h. Upon comple-
tion of incubation, media was removed, cells washed with PBS, and 200 µL DMSO was
pipetted in wells to dissolve the formazan product. Finally, 150 µL of formazan/DMSO
was transferred to a fresh 96 well plate and read on a colorimetric plate reader at 592
nm (background subtraction at 620 nm). All results are normalised to negative control
conditioned, media-treated MC3T3-E1 cell metabolic activity.
4.2.2 LIVE/DEAD® assay
Cell viability on esterified γ-PGA samples was evaluated using a LIVE/DEAD® stain
assay (Invitrogen). Primary human foreskin fibroblast cells-1 (HFF-1; ATCC, Virginia,
USA) were routinely cultured under standard conditions (37°C, 5% CO2, 100% humidity)
in grown in Dulbecco’s Modified Eagles Medium (DMEM) supplemented with 15% v/v
FBS and 1% v/v antibiotic-antimycotic (all Invitrogen).
Round samples 8 mm in diameter were punched and sterilised by UV light (2 h per
side) in polystyrene petri dishes. Following sterilisation, samples were transferred to 12
well plates containing 1 mL DPBS and soaked for 1 h at RT. After pre-wetting, HFF-1
cells (passage two, P2), were seeded at a density of 20,000 cells cm-2 with 50 µL cell
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suspension per film. Cells were allowed to attach for 1 h before 2 mL fresh media was
added. Samples were cultured, changing media every 2 days, for 1 and 7 days. Upon
completion of time points, cells were washed with DPBS and 1 mL sterile LIVE/DEAD®
solution (0.5 µM calcein AM and 0.5 µM ethidium homodimer-1 (EthD-1) in DPBS) was
added to each well. Plates were incubated at 37 °C for 30 min, after which fluorescence
was imaged on an Olympus IX51 epifluorescence microscope fitted with a DP-70 camera
(calcein peak excitation 494 nm, peak emission: 517 nm; EthD-1 peak excitation: 528
nm, peak emission: 617 nm).
4.2.3 Immunofluorescence staining
HFF-1 (P2) cells were cultured as above and seeded onto unoriented γ-PGA-Bn films (r =
6 mm) in 12-well plates at a low density of 3000 cells cm-1 in 50 µL volumes. Cells were
given 1 h to attach before adding 2 mL media into wells. Films were cultured at 37°C,
5% CO2 for 4 days, refreshing culture media at day 2. After culture period, the films were
stained as below and imaged using a Leica TCS SP2 upright confocal microscope (Leica
Microsystems GmbH, Wetzlar, Germany).
Cultured films were removed from the well plate, washed three times with DPBS (0.1
M, pH 7.4), and subsequently fixed with a solution of 4 % (w/v) paraformaldehyde in
DPBS for twenty min at room temperature. Films were then rinsed 3 times in DPBS and
then permeabilized using a Triton x-100 solution (0.25% v/v in DPBS) for five min at
RT, and washed 3 times. A 3% (w/v) solution of bovine serum albumin (BSA; Sigma)
in DPBS was applied and samples were allowed to block non-specific protein binding
for 1 h at RT. All subsequent steps were performed with samples protected from light to
preserve fluorescence.
After removal of the BSA solution, focal adhesions were stained with a 1:400 solu-
tion of vinculin (primary antibody, raised in mouse; Abcam, Cambridge, U.K.) in DPBS,
added to cover films and left to bind at RT for one h. Samples were washed three times
with DPBS and the secondary antibody, a goat α-mouse conjugated with Alexafluor 568
(Molecular Probes, Invitrogen), was added at a concentration of 1:400 in DPBS for 1
h at RT. The secondary antibody solution was removed, films washed three times with
DPBS, and conjugated Phalloidin-AlexaFluor 488 solution (1:400 in DPBS; Invitrogen)
was added to stain actin filaments for thirty min at RT. Samples were then rinsed three
times in DPBS, and a 1:1000 solution of 4’-6-Diamidino-2-phenylindole (DAPI) in DPBS
was added for 5 min to stain cell nuclei. Finally films were rinsed three times with DPBS,
placed on slides, mounted with a drop of ProLong® mounting medium (Invitrogen), cov-
ered with a cover slip, and sealed using clear nail varnish.
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4.2.4 Dissolution soaking study
For dissolution studies, unoriented γ-PGA-Bn films were cast as described in Section
5.2.2 and samples punched in two sizes, r = 4 and 9 mm for SEM and 1H-NMR character-
isation, respectively. Films were incubated in an orbital shaker (R.P.M. = 120; Weiss Gal-
lenkamp, Loughborough, UK) at 37°C for 7, 14, 21, and 28 days in diH2O, DPBS (PBS),
and simulated body fluid (SBF, as prepared according to Kokubo and Takadama [171])
Soaking volumes (V) were calculated based on surface area (S.A.) from the following
equation [171]:
V(ml) = S .A.(mm2)
10
(4.1)
The medias were changed every 7 days, reserving 1 mL of supernatant for UV-Vis mea-
surements, stored at RT.
UV-Visible spectroscopy
UV-Visible measurements were carried out on a JASCO-V-630 Spectrophotometer, col-
lecting spectra from 200-300 nm and using quartz cuvettes (optical pathway = 10 mm).
A calibration curve of benzyl alcohol was obtained by measuring absorbance at λ = 257
nm of 1, 2, 2.5, 4 and 5 mM solutions in diH2O, as shown in Figure 4.1.
Figure 4.1: UV-Vis calibration curve for benzyl alcohol absorbance at λ = 257 nm.
For each soaking time point, 1 mL of film supernatant (n = 3) was transferred into the
cuvette and absorbance measured using the corresponding blank (H2O, PBS, or SBF).
For time points over seven days, cumulative values of individual samples were averaged
across media types.
Scanning electron microscopy
Upon time point completion, films were gently washed with diH2O and air dried at room
temperature for 24 h, followed by 72 h at 40°C under vacuum. After drying, smaller
film samples (r = 4 mm) were massed and mounted on SEM stubs, sputter coated with
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chromium (75 µA, 1.5 min) and imaged using a Leo 1525 Gemini scanning electron
microscope operated at an accelerating voltage of 5 kV.
Optical photography
Upon time point completion, films were gently washed with diH2O and air dried at room
temperature for 24 h, followed by 72 h at 40°C under vacuum. Larger samples (r = 9
mm) were massed and then photographed using a Canon EOS 350D with a 24-70 mm
2.8f L-series Canon lens.
1H-NMR
Following optical photographs, films were cut and approximately 10 mg of the film was
dissolved in 500 µL DMSO-d6 for 1H-NMR to assess any side chain hydrolysis.
4.3 Results and Discussion
Though γ-PGA is non-toxic, the biocompatibility of the esterified polymers has yet to be
reported in the literature. Thus, cell culture studies were performed to assess if esterified
γ-PGA films are also non-cytotoxic and support cell attachment.
4.3.1 ISO 10993:5 pre-clinical cytotoxicity test
In order to assess the feasibility of modified γ-PGA films for use in tissue engineering
applications, [147] the ISO 10993:5 test was employed, a step often used prior to in vivo
animal studies. This test assesses if any toxic dissolution products are released, as they
will cause a detectable reduction in cellular metabolic activity level. Polymer films were
soaked in cell culture medium at 37°C for 7 days. Murine pre-osteoblastic cells (MC3T3-
E1) were then cultured in the conditioned medium overnight and their metabolic activity
assessed.
For the ISO 10993:5 test, cell metabolic activity was measured using an MTT [3-
(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay. The MTT assay is
a colourimetric assay that measures the enzymatic reduction of the yellow tetrazolium
salt (MTT) into an insoluble purple formazan product. This is performed by dehydro-
genases in the mitochondria of living cells and more enzymatic reduction reflects more
cellular metabolic activity.
MC3T3-E1 cells cultured in conditioned medium soaked with either the negative con-
trol or esterified γ-PGA films appeared morphologically normal (Figure 4.2, panels A-D,
F), while those exposed to positive control conditioned medium displayed a rounded,
abnormal morphology (Figure 4.2-C). Activity of cells exposed to all experimental film
soaked media were similar to that of the negative control as shown in Figure 4.3. The
MTT activity of positive control treated cells was significantly lower than all other tested
groups (p < 0.001).
These results indicate that dissolution products released from soaked films did not have
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a negative effect upon cell metabolic activity. Thus all esterified γ-PGA polymers pass
the international standard test for assessing in vitro mammalian cell cytotoxicity and have
good potential for use in tissue engineering applications. As this method of assessment is
performed with murine cells, it is of great interest to assess human cell viability directly
on the modified γ-PGA polymers, which will be described in the following sections 4.3.2
and 4.3.3.
Figure 4.2: MC3T3-E1 cells exposed to conditioned media for 24 h. A) Tissue culture
plastic (blank control), B) γ-PGA-Et, C) Negative control, D) γ-PGA-Pr, E) Positive con-
trol, F) γ-PGA-Bn.
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Figure 4.3: ISO 10993:5 pre-clinical test of esterified γ-PGA films, normalised to negative
control. All polymers passed and metabolic activities were not significantly different to
the negative control, but were significantly different from the positive cytotoxic sample (*
p < 0.001).
4.3.2 LIVE/DEAD® assay for cell viability
As the ISO 10993:5 test uses mouse cells for testing cytotoxicity, γ-PGA films were then
cultured to assess their ability to support human cell attachment and growth. Viability
of human foreskin fibroblast-1 (HFF-1) cells (P2) cultured on esterified γ-PGA films was
assessed using a LIVE/DEAD® assay at days 1 and 7 (Figure 4.4). The assay shows
live cells with intact cell membranes, which only fluoresce green from esterase cleaved
calcein AM in the cytoplasm. Meanwhile, ”dead” cells, which have compromised cell
membranes, allow EthD-1 to label nucleic acids with red fluorescence.
Day 1 images are shown at 10x magnification to display initial cell morphology after 24
h adhesion in areas of low-density, while Day 7 images are shown at 4x magnification to
show cell viability on a wider scale. All polymer films were found to have a large amount
of autofluorescence with both the blue and green excitation filters. At 24 h, all films
supported sparse cell attachment, while cells on γ-PGA-Et films appeared more round
while those on γ-PGA-Pr and γ-PGA-Bn were more spread.
Fibroblasts on all polymer types remained viable at both time points assessed in this
study, as confirmed by the LIVE/DEAD® stain. Visual examination of the images taken
at lower magnification on day 7 shows that cells spread and proliferated over time on all
three polymer types. These results, taken together with those from the ISO test indicate
that all three γ-PGA modifications have potential to be candidates for tissue engineering.
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Figure 4.4: LIVE/DEAD® assay of human foreskin fibroblasts (P2) cultured for 1 and 7
days on esterified γ-PGA films at 10x and 4x magnification, respectively.
As reported in the previous chapter, the contact angles of γ-PGA-Et, γ-PGA-Pr, and γ-
PGA-Bn were found to be 58.0° ± 0.7, 76.6° ± 1.1, and 88.1° ± 1.2 (not significant from
PLLA, 88.1° ± 1.4), respectively. Recently, Joy et al. [172] studied a focused library of
methacrylate terpolymers to investigate surface chemistry effects on cell function, ranging
in contact angle from 61° ± 2.37 to 96° ± 1.28. [172] Their group found that polymers with
contact angles ≥ 92.0° (± 1.8) had significantly higher cell attachment and proliferation
than those with lower contact angles. [172]
They also demonstrated a positive correlation for both cell attachment and proliferation
with increasing contact angle. For polymers with contact angles (61° ± 2.37 and 75° ±
2.37) [172] similar to those of γ-PGA-Et and γ-PGA-Pr, the measured percentages of cells
undergoing proliferation were found to be 24 % ± 3.06 and 29% ± 9.27, respectively. [172]
This level of proliferation was far lower than that of a polymer with a similar contact
angle (92.0° ± 1.83) [172] to γ-PGA-Bn (88.1° ± 1.2). This polymer with a larger contact
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angle displayed 78 ± 5.01% cells proliferating. [172] Therefore, the γ-PGA-Bn polymer
has been chosen to focus specifically on with further studies to look at cell attachment
and cytoskeletal organisation on this polymer using immunostaining techniques.
4.3.3 Immunostaining of cells
Following on the results from contact angle analysis as discussed in the previous section,
HFF-1 cells were seeded onto γ-PGA-Bn films and cultured for 4 days. Following com-
pletion of the time point, cells were stained to investigate their adhesion onto the polymer
substrate (Figure 4.5). HFF-1 cells grown on γ-PGA-Bn films stained positive for F-actin,
vinculin, and DNA, allowing the cytoskeleton and nucleus to be imaged. The cells were
found to be spread on the films with a large amount of actin fibre organisation in the di-
rection of cell elongation. It was also seen that vinculin was colocalised with actin stress
fibres (highlighted in Figure 4.6), indicating the fibroblasts are bound to the substrate by
focal adhesions.
The cells displayed F-actin stress fibres (green), a major component of the fibroblast
cytoskeleton which is linked to the cell membrane in focal adhesions [173]. In fibroblast
cells, actin exists primarily in three structures: the most prominent form of actin stress
fibres [174], cell surface protrusions including membrane ruﬄes and microspikes, and in
the cortical actin network. [173]. Stress fibres originate from focal adhesions, areas where
integrins cluster and bind to the extracellular matrix, as discussed in Section 1.2.4. De-
pending on the cytoskeletal organisation, it is possible to determine if the cells are motile
or stationary on substrates.
In 1978, Heath and Dunn [175] used electron microscopy to discover that some actin
bundles did not pass through the perinuclear region and had focal contacts associated
with both ends of the bundles. These cytoskeletal patterns were found to be more common
in cells with decreased motility. [175] This organisation was seen in some cells on the γ-
PGA-Bn films, as seen in Figure 4.5-B and highlighted in Figure 4.6-A. Heath and Dunn
also observed that some cells possessed a star-shaped organisation of filament bundles
where bundles terminate at focal adhesions and were radially arranged from a common
centre, [175] as seen in some HFF-1 cells grown on γ-PGA-Bn films in Figure 4.5-D and
highlighted in Figure 4.6-B.
The organisation and staining observed for F-actin and vinculin indicate that the human
fibroblast cells are well adhered to the γ-PGA-Bn films. This is a promising result for hu-
man tissue engineering applications as cell adhesion plays a significant role in numerous
cell processes.
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Figure 4.5: Immunostained images of HFF-1 (P2) cells cultured on γ-PGA-Bn films for
4 days at 37°C, 5%CO2. Confocal images taken at 20x (A), 40x (B), and 63x (C-D)
magnification. Blue represents cell nuclei, green shows F-actin filaments and red displays
vinculin-positive focal adhesions.
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Figure 4.6: Areas of interest from immunostained images shown in Figure 4.5 of HFF-
1 (P2) cells cultured on γ-PGA-Bn films for 4 days (37°C, 5%CO2), displaying F-actin
stress fibres associated with focal adhesions at both ends of the fibres highlighed in yel-
low boxes (A) or radially arranged focal adhesions highlighted in purple boxes (B). Blue
represents cell nuclei, green shows F-actin filaments and red displays focal adhesions.
4.3.4 Dissolution soaking study
Following cell cytocompatibility and viability tests, a dissolution study was performed
to investigate the stability of γ-PGA-Bn films. While the native γ-PGA is enzymatically
degraded, the ester group on the side chain can still be subject to random hydrolysis,
yielding benzyl alcohol byproduct and rendering the main chain more soluble. Films
were soaked for 7, 14, 21, and 28 days at 37°C to assess any side chain hydrolysis and
resultant dissolution.
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Mass retained
Over the soaking period, all films had significantly less mass than starting, experiencing a
loss of 3-4%, as shown in Figure 4.7. The largest drop in mass occurred in the first seven
days, independently of soaking media.
Figure 4.7: Mass retained for films soaked in a) H2O, B) PBS, or C) SBF for 7, 14, 21,
and 28 days at 37°C. Significance determined by One-way ANOVA (Tukey post-hoc) and
as indicated in figure.
Side chain hydrolysis
Supernatants from the soaking media at each time point and media changes were run un-
der UV-Visible spectroscopy (UV-Vis) to test for any optical change due to benzyl alcohol
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being released in the solution. The absorbance levels detected were below that of the low-
est concentration in the calibration curve (1 mM BnOH) and appear to be instrumental
noise. Therefore, if any benzyl alcohol was released, the concentration is less than 1 mM
BnOH and too low to detect using this method.
Alternatively, dried films from each time point were sent for 1H-NMR analysis to detect
any change in esterification level of the films. No change was detected in any of the sam-
ples at any of the time points. Thus it may be concluded that if any side chain hydrolysis
occurs, it is below a level which the instrument can detect.
Optical photographs
Polymer film transparency decreased upon soaking after 7 days in all three media. Some
films were curled upon retrieval, while others remained flat. There was no visible change
in colour or opacity after 7 days, and all films maintained their integrity throughout the
soaking experiment duration. This optical change is from the unsoaked films is shown in
Figures 4.8 and 4.9. The Tg of batches is 62°C, as determined by DSC, so the observable
change is not due to crystallisation of the polymer film. Scanning electron microscopy
was employed to investigate this change further and see if any microscale changes took
place.
Figure 4.8: Optical photographs of films as cast or soaked in H2O for 7, 14, 21, and 28
days at 37°C.
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Figure 4.9: Optical photographs of films soaked for 7, 14, 21, and 28 days in PBS or SBF
at 37°C.
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Scanning electron microscopy
As shown in Figure 4.7, all films experienced around a 2% mass loss by day 7. A change
in opacity is also observed optically as shown in Figures 4.8 and 4.9. Scanning electron
microscopy images of pristine, as cast films (Figure 4.10) show no obvious defects, such
as holes or cracks at 10,000 and 25,000x magnification.
By day 7, however, soaked films start to develop submicron sized holes which appear
lighter in contrast than the film surface. These defects may cause a refraction of light,
distorting its path through the polymer film and causing a visible change in transparency.
Later time points show more occurrence of these defects. By day 28 in the SBF solution,
widespread surface dissolution takes place, shown by a large change in contrast of the
film surface. Backscattering SEM confirmed there was no mineralisation on the films
soaked in SBF, and there was no precipitation of salt or mineral from any of the soaking
media. This method also confirmed the holes were a direct result of dissolution from the
film surface.
These defects appeared more frequently in the salt-containing solutions (PBS and SBF)
than H2O. While the γ-PGA-Bn is water resistant, the native γ-PGA-Na+ salt form is
extremely soluble at neutral pH. If any side chain hydrolysis occurred, the hydrolysed
regions would be charge balanced by the ions in the PBS or SBF solutions. It is specu-
lated that this may introduce even more water to the local environment, causing further
hydrolysis of nearby polymer regions.
Figure 4.10: Scanning electron microscope photographs of films as cast. Scale bars = 1
µm.
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Figure 4.11: Scanning electron microscope photographs of films soaked for 7, 14, 21, and
28 days in H2O at 37°C. Scale bars = 1 µm.
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Figure 4.12: Scanning electron microscope photographs of films soaked for 7, 14, 21, and
28 days in PBS at 37°C. Scale bars = 1 µm.
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Figure 4.13: Scanning electron microscope photographs of films soaked for 7, 14, 21, and
28 days in SBF at 37°C. Scale bars = 1 µm.
Since their FDA approval, the dissolution of biodegradable polyesters has been well
documented over the decades. Depending on the polymer backbone, these polymers can
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take anywhere from days up to 2 years to dissolve in the body. In 28 days, no side
chain hydrolysis of benzyl-esterified γ-PGA could be detected using UV-Vis and 1H-
NMR, indicating this polymer is likely to maintain the same level of water resistance.
This is encouraging for tissue engineering applications as this polymer resists dissolution
and should still be mainly enzymatically degraded like the native starting polymer.
4.4 Conclusions
All esterified γ-PGA films passed the ISO 10993:5 test, indicating they are non-cytotoxic.
Human fibroblast cells were supported on all polymer types and viable for up to seven
days. Fibroblasts cultured on γ-PGA-Bn films showed cytoskeletal organisation including
stress fibres and focal adhesions, indicating they adhered well to the films. Soaked films
of γ-PGA-Bn significantly lost 3-4% mass in 28 days, independent of soaking media.
Opacity of all films increased slightly and submicron surface holes were detected after
seven days using SEM. These surface defects appeared more prominent in salt containing
soaking medias (PBS and SBF), with widespread surface changes visible on SBF soaked
films at 28 days. This change was undetectable using UV-Vis, indicating less than 1
mM BnOH was released, and any change in esterification level was indistinguishable
by 1H-NMR. Therefore, as expected, the majority of γ-PGA-Bn degradation should be
enzymatic and fair, ideal degradation testing is reliant on future in vivo studies.
It would be advantageous to have a larger amount of synthesised product to perform
more extensive mechanical characterisation, as well as cellular differentiation studies us-
ing stem cells. To do so, the synthesis must be scaled up, which is the focus of the next
chapter.
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Chapter 5
Enhancing mechanical properties of
esterified γ-PGA polymers using tensile
deformation
5.1 Introduction
For regenerative medicine applications, γ-PGA was esterified as described in the previous
chapter to increase the water resistance of the polymer and make it a suitable candidate for
scaffold fabrication. Designing products with appropriate mechanical properties presents
a challenge for tissue engineers as these properties vary depending on the target replace-
ment tissue (shown in Figure 1.5). Therefore, due to natural variation between patients,
the ability to tailor scaffold properties may offer a wider market for customised medical
product commercialisation.
One widely used technique to enhance mechanical properties of polymeric materials is
tensile deformation. This method utilises mobility within amorphous regions of semicrys-
talline polymer chains, when above the glass transition temperature and in Van der Waals
bonded crystalline entities, subjecting them to a uniaxial tensile force, inducing orienta-
tion in the direction of tension. Tensile deformation relies on a phenomenon known as
cold drawing, pioneered by Carothers and Hill in 1932, whose work led them to propose
orientation was “probably necessary for great strength and pliability.” [176] Since then, the
polymer industry has investigated and refined making ultra-high strength fibres and films
by orienting polymer chains and inducing macromolecular order for various applications.
For instance, fibres made from ultra-high molecular weight polyethylene, nowadays are
produced with a Young’s modulus of over 100 GPa, [148] allowing adaptation for numerous
applications ranging from bullet-proof vests to high-performance surgical sutures.
This chapter focuses on mechanical properties of the γ-PGA polymers, as produced in
Chapter 2, and exploring how to tailor these properties for appropriate tissue engineer-
ing applications. Very recently, de Oca et al. performed degradation studies on highly
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oriented poly(glycolic acid) fibres they produced using the above-referred tensile defor-
mation process to investigate the effect on mechanical properties. [177] When included in a
copolymer, this biodegradable polyester could be highly oriented, yielding Young’s mod-
uli of over 20 GPa. [178,179] This work represents the first time mechanical potential of
enzymatically degradable polymers is investigated in this manner, as well as the first time
modified γ-PGA is tailored using tensile deformation.
As discussed in sections 2.3.5 and 2.3.6, esterification decreased the water resistance
while the polymer thermal processing window between the glass transition temperature
and the onset of 5% degradation beneficially increased. Unfortunately, however, the dis-
covery of thermal degradation upon the onset of melting precludes traditional polymer
processing from the melt. Therefore, in order to orient these modified γ-PGA polymers,
solution-processing techniques, followed by tensile deformation, were employed to pro-
duce oriented, esterified γ-PGA polymers.
As discussed in the previous chapter, esterification of γ-PGA yielded limited quantities
of material with large batch inconsistency. This variability, seen in degree of esterification,
thermal properties, and notably, weight average molecular weight (Mw), is well known to
have a significant effect on orientation potential, and thus maximal achievable mechanical
properties. [180,181]
It is anticipated that separate synthesis batches will display differing mechanical prop-
erties. In order to limit these variables, the results presented here are obtained with a
single synthesised batch of each modification, using the method described in Chapter 2.
5.2 Experimental
5.2.1 Materials
Esterified γ-PGA polymers were used as synthesised (γ-PGA Na+ salt purchased as be-
fore) according to Chapter 2 and are characterised in Section 5.1. Perfluorotrichlorosilane
was purchased and used as received from ABCR (Karlsruhe, Germany). Unless indicated
otherwise, all other reagents and solvents were purchased from Sigma-Aldrich and used
as received.
5.2.2 Sample preparation
Esterified γ-PGA samples were dissolved at room temperature in HFIP (2% wt wt−1)
subsequently poured into the fluorinated glass petri dishes, covered and the solvent was
allowed to evaporate at RT for 48 h, followed by 24 h under vacuum at 60°C to remove
any remaining solvent. γ-PGA-H was dissolved in diH2O (2% wt wt−1), allowed to evap-
orate at RT for 96 h, and then placed under vacuum to prevent rehydration. Sample
concentrations were calculated to produce films approximately 100 µm thick.
N.B. For convenient removal of solution cast films, glass petri dishes (r = 3.5 cm)
108
5.2 Experimental
Table 5.1: Structure and properties of polymers used in this work as produced in Chapter
2. Glass transition temperature, Tg, and melting temperature, Tm, of native powder were
determined by differential scanning calorimetry; average molecular weight, Mw, calcu-
lated from size-exclusion chromatography.
Chemical structure Polymer Tg /°C Tm /°C Mw /g mol-1
γ-PGA -H1 124 2402 4.89x105
γ-PGA -Et 66 260 2.75x105
γ-PGA -Pr 40 228 1.97x105
γ-PGA -Bn 40 2263 3.22x105
1SEC performed under different conditions than esterified γ-PGA s (refer to Chapter 2.2.2)
2Degradation detected in TGA prior to melting
3Double endotherm, second peak at 240°C
were treated with a fresh Piranha solution of 70/30 sulphuric acid/hydrogen peroxide for
1 h and subsequently washed with excess water. The petri dishes were then placed in a
dessicator with a few drops of perfluorotrichlorosilane, evacuated to 20 mbar, left under
vacuum to fluorinate overnight, and annealed at 100°C for one h in vacuum.
5.2.3 Room temperature tensile testing and tensile deformation
Initial mechanical testing of as-cast, dried films was performed at room temperature with
an Instron Tensile Tester Model 5864 (Norwood, USA) with hydraulic clamps (5 bar) at
a cross-head speed of 2 mm min-1. Dumbbell shaped strips of 1.2 mm width and 4.5 mm
gauge length were cut from the dried films.
In a second series of experiments, tensile deformation of the dried esterified γ-PGA
films was performed above their respective Tg, using a using an Instron Tensile Tester
(Model 5864) fitted with an environmental chamber (Model EC43) at a cross-head speed
of 2 mm min-1. Dumbbell shaped strips were cut as for RT testing; ink marks were printed
at 1 mm intervals prior to drawing to determine draw ratios (λ = final/initial length) from
their displacement. γ-PGA-Et and γ-PGA-Pr samples were drawn at 125°C while γ-PGA-
Bn samples were drawn at 115°C, as maximum draw ratios (λmax) were achieved at these
respective temperatures.
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5.3 Analysis
5.3.1 Mechanical testing
Following tensile deformation above Tg and determination of the draw ratios from the ink
mark displacements, samples were then cut and glued using Al-Fix glue (Novatio; Olen,
Belgium) between card frames (separation distance = 10 mm), and allowed to dry for 2 h
under 200 g weights to ensure a strong bond. Sample width was measured using an optical
microscope, while thickness was determined using a micrometer. Mechanical testing of
the different samples was then performed at RT using hydraulic clamps as above, at a
cross-head speed of 5 mm min-1.
5.3.2 Optical microscopy
Optical microscopy was carried out with a Leica DMRX polarising microscope equipped
with a Leica DFC 480 Camera (both Wetzlar, Germany).
5.3.3 Wide-angle x-ray scattering (WAXS)
WAXS experiments were performed by Y. Odarchenko and Dr. D. Ivanov (Institut de Sci-
ences des Materiaux de Mulhouse, UHA Mulhouse) on the BM26 beamline of the ESRF
(Grenoble, France) using a Frelon detector positioned at approximately 6 cm from the
sample. This sample-to-detector distance allowed recording of the signals in the s-range
(s = 2 sin θ/λ, where θ is the Bragg angle) from 0.03 to 0.52 Å−1 using the wavelength
of 1.04 Å. Additional measurements were carried out on a custom-build SAXS/WAXS
machine (Molecular Metrology) coupled to a Rigaku MicroMax-007HF rotating anode
generator. The 2D WAXS data were collected in vacuum using Fuji image plates with the
pixel size of 100 x 100 µm2. The modulus of the scattering vector was calibrated using
diffraction orders of silver behenate in both setups. The measurements were performed
in transmission mode on the oriented samples (films with a thickness in the range 0.1-0.3
mm).
5.3.4 Polarised Raman spectroscopy
Raman measurements were performed by Y. Odarchenko and Dr. D. Ivanov (Institut
de Sciences des Materiaux de Mulhouse, UHA Mulhouse), and carried out on a confocal
Raman microspectrometer Labram-BX 40. The 632.81 nm excitation polarised light from
a HeNe laser light source was focused through a 50 x/0.95 objective (Olympus; Japan)
onto flat oriented films fixed in a holder specially designed to eliminate the signal from the
substrate. The laser power was 5 mW. The device calibration was conducted using the Si
peak at 520 cm−1. A single spectrum was recorded after integration of 50 measurements.
The direction of polymer chain orientation was parallel to the X direction of the inci-
dent beam. The polarisation direction of the incident beam was rotated with the help of a
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λ/2 plate by 90° (Y direction). In total, four Raman spectra were acquired with polarisa-
tion geometries X|X, X|Y, Y|X and Y|Y, using the notation incident polarisation|emitted
polarisation as shown in Figure 5.1.
Figure 5.1: Coordinate system used for recording of the polarised Raman spectra of the
glutamate films. The incident beam is polarised in the X-direction or Y-direction.
5.3.5 Thermal analysis
Polymer films were characterised in the same manner as synthesised powders in Section
2.2.2. Drawn samples were tightly rolled and the rolls were flattened to maintain align-
ment throughout DSC analysis until complete melting occurred.
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5.4 Results and discussion
5.4.1 Room temperature tensile properties of as-cast films
Initial tensile tests were performed at RT to determine mechanical characteristics of the
isotropic, as-cast, dried films, both of the native γ-PGA-H and its esterified forms. Typical
stress-strain curves recorded for the polymers are presented in Figures 5.2 and 5.3, while
their corresponding mechanical properties, Young’s modulus E, yield stress σy, tensile
strength σ, and strain at break , are presented in Table 5.2.
As expected, due to hydrogen bonding between carboxylic groups, the native γ-PGA-H
films were found to be brittle when tested at room temperature (Figure 5.2 and Table 5.2).
As shown in the nominal stress-strain plots in Figure 5.3, esterification of the γ-PGA-H
side chain resulted in highly enhanced ductility, as seen in a dramatic increase in the strain
at break of as much as 50, 150, and 250 times that of γ-PGA-H in γ-PGA-Bn, γ-PGA-
Pr, and γ-PGA-Et, respectively (Figure 5.3). As expected, however, this highly beneficial
enhancement was accompanied by a decrease in values of the stiffness E, and of the yield-
and tensile strength (Table 5.2).
Figure 5.2: Typical nominal stress/strain curve recorded at room temperature for the na-
tive γ-PGA-H films.
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Figure 5.3: Nominal stress/strain curves recorded at room temperature for esterified γ-
PGA films.
Table 5.2: Mechanical characteristics at room temperature of differently esterified γ-PGA
films tested at room temperature.
Polymer E/ GPa σy/ MPa σ/ MPa / %
γ-PGA-H 4.99 - 94 2
γ-PGA-Et 0.85 14.7 7.33 542
γ-PGA-Pr 1.37 29.2 14.4 361
γ-PGA-Bn 1.24 28.1 20.3 106
5.4.2 Tensile deformation
As a first step, stress-strain curves were recorded in the temperature range from RT-Tm
in order to establish the maximum draw ratio (λmax = /100 + 1) for subsequent tensile
deformation experiments. It was found that all modified films could be drawn to remark-
ably high draw ratios, generally above λ ≥ 10 at the optimum temperature (125°C for both
γ-PGA-Et and γ-PGA-Pr, and 115°C for γ-PGA-Bn). Above these temperatures, λmax
rapidly reduced due to excessive macromolecular mobility, as is commonly observed for
weakly interacting polymers, such as polyethylene [148,182]. It was found that γ-PGA-H
film could not be drawn to appreciable draw ratios; this is likely due to a high Tg and the
limited temperature window between Tg and the onset of degradation, caused by hydrogen
bonds between the chains.
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5.4.3 Mechanical properties of drawn films
The different esterified γ-PGA films were drawn at their optimum deformation temper-
atures to various draw ratios and subsequently subjected to tests at room temperature to
determine their mechanical properties. Polymer films were drawn to λ ≤ 10 to produce
a comparable set of results between the polymers with different side chains. Nominal
stress-strain curves of these drawn films are presented in Figures 5.4, 5.5, and 5.6 for
γ-PGA-Et, γ-PGA-Pr, and γ-PGA Bn, respectively. In all cases, the draw ratio was mea-
sured from initial ink mark displacement as indicated in these graphs. Common to all
esterified polymer samples, both Young’s modulus and tensile strength rapidly increased
with increasing draw ratio, while the strain at break decreased, as is commonly observed
for oriented polymers.
Figure 5.4: Nominal stress/strain curves recorded at RT of drawn γ-PGA-Et films drawn
at 125°C. Draw ratios are indicated in the figure.
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Figure 5.5: Nominal stress/strain curves recorded at RT of drawn γ-PGA-Pr films drawn
at 125°C. Draw ratios are indicated in the figure.
Figure 5.6: Nominal stress/strain curves recorded at RT of drawn γ-PGA-Bn films drawn
at 115°C. Draw ratios are indicated in the figure.
These characteristic trends are more quantitatively shown in Figure 5.7, in which the
values of E, σ, and  are plotted as a function of the draw ratio, λ, for all three γ-PGA
films. These plots display the positive relationship between λ and E, as well as the negative
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development of  with λ. These consistent correlations are indicative of increased polymer
chain orientation in the tensile direction, as discussed in later sections of this chapter.
Maximum values of the mechanical characteristics of the drawn films produced in this
study, compared to those of the as-cast polymers, are presented in Table 5.3.
Figure 5.7: Influence of tensile deformation on Young’s modulus, E, tensile strength, σ,
and strain at break, , at RT for all polymers studied.
From this data presented it can be concluded that by drawing to λ = 10, the modulus of
γ-PGA-Et increased by a factor of about 4.5 and the tensile strength improved by over a
factor of 13. Benzyl esterified γ-PGA offered the highest modulus, with a 4.3 fold increase
to 5.36 GPa. The maximum tensile strength achieved with γ-PGA-Bn was found to be
149 MPa, a dramatic increase of more than 5-fold, but still inferior to that of γ-PGA-Et.
Drawing γ-PGA-Pr resulted in a nearly double value of its modulus and tripled the tensile
strength, with only a 10-fold decrease in strain at break.
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Table 5.3: Mechanical properties of esterified γ-PGA films as-cast and maximum proper-
ties achieved by drawing to λ = 10.
Polymer Film E/ GPa σ/ MPa / %
γ-PGA-Et As-cast 0.85 14.7 542
Drawn 3.85 196 16.1
γ-PGA-Pr As-cast 1.37 29.2 360
Drawn 2.54 109 36
γ-PGA-Bn As-cast 1.24 28.1 106
Drawn 5.36 149 7.3
Figure 5.8: Tensile strength vs. stiffness of the present polymer series compared with
human tissues in the Ashby style plot presented earlier (Section 1.2.2).
In accord with results obtained with common polymers by using tensile deformation,
the above results clearly indicate that the mechanical properties were greatly enhanced
for all γ-PGA films. Most importantly, properties achieved approached similar values to
those of soft human tissues (cf. Figure 5.8); yet their strain at break remained at or above
a physiologically relevant 7%.
An interesting phenomenon was discovered upon retesting drawn polymer samples
again at room temperature. At draw ratios approximately λ > 5, a double yield point
in the stress-strain curves was observed upon retest for all three polymer species. This
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double yield point could be indicative of an α-helix conformation of the macromolecules,
as will be discussed in the section on wide-angle X-ray scattering analysis.
5.4.4 Estimated theoretical chain stiffness
As previously reported, it is possible to estimate the theoretical maximum stiffness of
a single chain, or perfectly ordered, uniaxially arranged crystal, from the development
of the Young’s modulus with draw ratio of flexible chain molecules. [183] That maximum
value of E, can be estimated according to the following relation, in its simplified form
(Equation 5.1 [183]) for λ ≥ 5 reads:
E = (︀E−1h + (E−1u − E−1h )(3pi4 )λ−3⇑2⌋︀−1 (5.1)
where Eh is the theoretical maximum Young’s modulus and Eu that of perfectly isotropic
material - in the theory denoted as referring to those of “helix” and “coil” segments.
Employing the data present in Figure 5.7, the following estimates for Eh were obtained
(Table 5.4). Also indicated in this table are the standard error and correlation of the
calculations.
Table 5.4: Calculated theoretical moduli for esterified γ-PGA films using Equation 5.1.
Modulus γ-PGA-Et R2 γ-PGA-Pr R2 γ-PGA-Bn R2
Eu /GPa 0.85 - 1.37 - 1.24 -
Eh /GPa 4.64 ± 0.46 0.766 2.52 ± 0.29 -0.175 5.26 ± 0.61 0.624
Euc /GPa 0.5 ± 0.09 0.869 0.51 ± 0.19 0.137 0.4 ± 0.06 0.692
Ehc /GPa 7.2 ± 1.74 0.869 3.5 ± 0.79 0.137 12.56 ± 4.52 0.692
In the approach of Irvine and Smith, [183] a uniform distribution of stress in the helix
and coil elements was assumed. In the table above, the measured “unoriented” modulus,
Eu, and a calculated, perfectly unoriented modulus Euc with the corresponding Ehc are
also presented. Unfortunately, due to the nature of solution casting, γ-PGA films may
have some orientation in the direction of tension, and the experimental value of Eu could
introduce error in the calculations. Accordingly, all calculations for Eh were performed
also employing Euc, as determined by fitting both Euc and Eh. Furthermore, inclusions
of impurities from the chemical synthesis and purification steps in the films resulted in
scatter of the data as shown in Figure 5.7. Thus, justifiably, only the maximum values
achieved at the various draw ratios were used, as these are closest to the true values
achievable for an optimal material.
Reviewing the above results, it is not surprising that the ethyl-modification featured a
higher value of Eh than its propyl counterpart. Somewhat surprising, however, the most
bulky substituent, benzyl, appears to be the highest value for the γ-PGA.
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5.4.5 Structural characteristics
Polarised optical microscopy
Polarised optical microscopy was employed to investigate the increase in macromolecular
orientation in the drawn polymer samples. Figure 5.9 shows two tapes overlaid at ∼90°
of all esterified polymers, oriented to λ ≥ 10, under cross-polarised light. Orientation
was observed with a maximum light intensity at ±45° to the polarisers, while no light
was observed through the samples at 0° and 90°, indeed indicative of a high degree of
uniaxial macromolecular order in the various tapes. The addition of a quarter wavelength
retardation plate, displays both a subtractive (yellow) and additive (blue) effect through
the oriented samples.
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Figure 5.9: Polarised optical microscopy images of overlayed, 10 times drawn polymer
films γ-PGA-Et (A,B) γ-PGA-Pr (C,D), and γ-PGA-Bn (E,F). Orientation is seen using
both normal polarized light (A,C,E) and with the use of a quarter wavelength retardation
plate (B,D,F).
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Wide-angle x-ray scattering
Structural features of the drawn films, and in particular the macromolecular orientation
therein were also investigated by means of wide-angle x-ray scattering (WAXS). A typical
diffraction pattern of a γ-PGA Et film drawn at 115°C to λ = 9, and annealed at 145°C for
5 min to further promote molecular order, is presented in Figure 5.10. Clearly, the pattern
is indicative of a high degree of uniaxial orientation of the polymer in the direction of
deformation.
Figure 5.10: Wide-angle x-ray scattering of γ-PGA-Et film, λ = 9, drawn at 115°C and
annealed at 145°C for 5 min, drawing direction vertical.
The WAXS data were employed to determine the crystal lattice parameters of γ-PGA-
Et, which was found to be orthorhombic (see Table 5.5). The crystal density was calcu-
lated to be ρcal = 1.36 g cm−3, which is in modest agreement with the density of 1.25 g
cm−3 measured in KI water solution.
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Table 5.5: Calculated WAXS lattice parameters from Figure 5.10 for γ-PGA-Et, oriented
to λ = 9.
Layer line hkl dexp/ Å dcalc/ Å Intensity
l=0 200 9.24 9.2 w
010/400 4.61 4.55 vs
210 3.76 4.08 w
600/510 2.89 3.07 vw
800 2.38 2.28 w
l=1 101 8.1 8.18 s
201 6.59 6.48 s
301 5.1 5.09 w
011/401 4.17 4.07 vs
311/501 3.49 3.39 w
801 2.22 2.23 vw
l=2 002 4.55 4.57 w
202 4.12 4.09 s
302 3.67 3.66 w
412 2.7 2.64 vw
l=3 303 2.72 2.73 vw
403 2.58 2.54 vw
503 2.37 2.35 vw
Lattice parameters
Orthorhombic; P21221; for (h00) and (00l) h,l=2n
a=18.40 Å, b=4.55 Å, c=9.13 Å
The WAXS pattern of γ-PGA-Pr was found to be similar to that of γ-PGA-Et, except
that it featured better resolved diffraction peaks, which is attributed to the higher draw
ration of the films (Figure 5.11). Also, in the of γ-PGA-Et pattern the (010) and (400)
peaks overlap. Hence, the diffraction diagram of γ-PGA-Pr, where these peaks can be
distinguished, was examined first (Table 5.6).
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Figure 5.11: Wide-angle x-ray scattering of γ-PGA-Pr film, λ = 13, drawn at 120°C and
annealed at 145°C for 5 min, drawing direction vertical.
The meridional peak appears on the second layer line, which could indicate a 2/1 helical
conformation with a subunit parameter of 4.66 Å, or the c-parameter of 9.23 Å. The
observed peak is relatively weak. To examine the possible meridional peaks of higher
order, the fiber was tilted by 20°. In this case, only the second order of 002 reflection, or
004 peak were observed.
The a-parameter was calculated from the smallest equatorial projection of the reflection
on the 1st layer line (a ∼ 20 Å). The obtained value is bigger than 14.5 Å, corresponding
to the fully extended lateral ester groups pointed in opposite directions. This means that
there is more than one chain in the a-direction. The b-parameter was computed from
the position of the first strong equatorial peak, which is not an order of (100). If one
assumes that the orthorhombic unit cell of the compound consists of 4 monomer units,
the calculated crystal density is ρcal=1.29 g cm-3. This is in reasonable agreement with
the observed density of 1.23 g cm-3, determined for a semicrystalline sample in an aqueous
KI solution.
As far as the molecular conformation within the unit cell is concerned, it is tentatively
concluded that it consists of layers stabilised by intermolecular hydrogen bonds.
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Table 5.6: Calculated WAXS lattice parameters from Figure 5.11 for γ-PGA-Pr, oriented
to λ = 13.
Layer line hkl dexp/ Å dcalc/ Å Intensity
l=0 200 10.04 10.04 s
400 4.99 5.02 w
010 4.69 4.76 vs
210 4.36 4.3 w
310 3.89 3.88 s
600 3.34 3.35 w
020 2.4 2.38 vw
l=1 101 8.36 8.39 s
201 6.88 6.79 s
301 5.43 5.42 m
011 4.22 4.23 vs
311 3.61 3.68 m
701 2.73 2.74 vw
l=2 002 4.66 4.62 m
202 4.23 4.19 s
302 3.79 3.8 s
012 3.35 3.31 w
412 2.76 2.76 vw
612 2.36 2.35 vw
l=3 303 2.8 2.8 w
403 2.6 2.62 vw
503 2.45 2.44 vw
l=4 004 2.12 2.31 vw
Lattice parameters
Orthorhombic; P21221; for (h00) and (00l) h,l=2n
a=20.07 Å, b=4.76 Å, c=9.23 Å
The corresponding WAXS pattern and calculated lattice parameters for γ-PGA-Bn, ori-
ented to λ = 13.5 are presented in Figure 5.12 and Table 5.7, respectively.
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Figure 5.12: Wide-angle x-ray scattering of γ-PGA-Bn film, λ = 13.5, drawn at 115°C .
Table 5.7: Calculated WAXS lattice parameters from Figure 5.12 for γ-PGA-Bn, oriented
to λ = 13.5.
Layer line hkl dexp/ Å dcalc/ Å Intensity
l=0 200 12.17 12.04 s
010 4.63 4.58 w
210 4.21 4.28 w
l=1 401 5.77 6.26 vw
501 4.38 4.34 vw
l=2 202 4.73 4.57 s
302 4.3 4.26 w
l=3 203 3.32 3.22 w
l=4 004 2.54 2.51 vw
204 2.36 2.32 vw
Lattice parameters
Orthorhombic; P21221; for (h00) and (00l) h,l=2n
a=24.06 Å, b=4.58 Å, c=10.05 Å
The 2D WAXS pattern of γ-PGA-Bn was found to feature only a few diffraction peaks.
The model used to analyze the above ethyl- and propyl-substitued samples was applied,
but slightly modified due to the presence of the aromatic ring. The data recorded indicated
that this polymer is also of an orthorhombic crystalline nature. The calculated crystal
density is ρcal=1.25 g cm-3, which is well below the measured density of 1.40 g cm-3,
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determined by pycnometry, for reasons yet unclear. The lattice parameters obtained for
γ-PGA-Bn are similar to those previously published [184], which was reported to indicate
a 5/2 α-helical confirmation.
Polarised Raman spectroscopy
Polarized Raman spectra recorded in the region 1000-3600 cm−1 of unoriented and ori-
ented polymer films are presented in Figures 5.13 A-C. The notation X|X represents spec-
tra recorded parallel to the direction of film orientation, while Y|Y spectra were perpen-
dicular to the direction of film orientation. Almost no signal was observed in the cross
polarised geometries, i.e. X|Y, Y|X. Characteristic Raman peaks are observed at 3295
cm−1 (Amide A, v ν N-H), 1642 cm−1 (Amide I, v ν C=O), 1607 cm−1 (Amide II, v ν C-N
+ δ N-H), 1294 cm−1 (Amide III, δ N-H).
The Y|Y spectra show higher intensity for N-H and C=O stretching vibration bands at
3295 cm−1 and 1642 cm−1 in comparison with X|X spectra for the samples with shorter
alkyl lateral chains (Figure 5.13 A, B). This difference was not observed for the the
benzyl-substituted material.
The amide II band was not observed for alkyl-esterified γ-PGA polymers, which may
be due to an α-helical structure. Janko et. al reported on anisotropic Raman scattering
in collagen bundles, which showed that typical amide Raman peaks of the protein back-
bone change depending on alignment. [185] They found the stabilisation of the triple helical
structure in collagen, formed by interchain H-bonds between N-H and C=O bonds (in col-
lagen, bonds of glycines and prolines, respectively), are represented by the amide I and
amide III bands. [185]
Table 5.8: Common Raman shift values for secondary protein structures, as reproduced
from [28].
Structure Amide I / cm−1 Amide III / cm−1 Skeletal C-C / cm−1
α-Helix 1660-1645 1310-1260 950-885
β-Pleated sheet 1680-1665 1240-1225 1010-1000
Random coil 1680-1665 1260-1240 960-950
However, the amide II peak for the γ-PGA-Bn film shows dichroism, which corre-
sponds to the conventional orientation of the macromolecule in a fibre. Also, the ob-
served dichroic ratios for γ-PGA-Et and γ-PGA-Pr samples are expected for a structure
with C=O and N-H bonds oriented normal to the chain axis [184]. Thus the Raman data
generally confirm the proposed structural model.
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Figure 5.13: Raman spectra recorded in X|X (red) and Y|Y(blue) orientations for oriented
A) γ-PGA-Et, B) γ-PGA-Pr, and C) γ-PGA-Bn polymer films.
Thermal analysis
Higher draw ratios were found to thermally display an increase in degree of crystallinity.
In lieu of exact calculations for the material’s crystalline percentage, which are reliant
on knowing the exotherm of a perfect polymer crystal, the ratio of normalised exother-
mic and endothermic heat flows are presented in Table 5.9. As draw ratio increases,
the exotherm associated with crystallisation decreases in area while melting remains un-
changed. This is true for all modified γ-PGA polymer species, and is shown graphically
127
5 Enhancing mechanical properties of esterified γ-PGA polymers using tensile deformation
from the first heating DSC traces in Figures 5.14, 5.15, and 5.16 for γ-PGA-Et, γ-PGA-
Pr, and γ-PGA-Bn, respectively. All polymers were then melt-crystallised and did not
display any crystallisation in second heating traces.
Samples of the various esterified PGAs, both as-cast and oriented, were also analysed
by differential scanning calorimetry (DSC), in order to explore their thermal proper-
ties. Typical DSC-thermograms of the various materials are presented in Figures 5.14-
5.16. Interestingly, as-cast, dried films (λ = 1) of all modified polymers featured a well-
defined glass transition temperature and a pronounced crystallisation endotherm. The
latter rapidly diminished with increasing draw ratio in all cases, indicative of orientation-
induced crystallisation of the macromolecules.
Unfortunately, the relatively poor quality of the DSC-traces did not permit a reliable
determination of the various values of the melting enthalpy. Furthermore, it would not be
possible to extract degrees of crystallinity as their values for 100% crystalline material are
not known. Thus, the ratio of the melting endotherm and the exothermic enthalpy of crys-
tallisation recorded in the first heating cycle was chosen to represent the development of
crystalline order with draw ratio. These data are presented in Table 5.9. The latter reveal
that all as-cast, dried films were essentially amorphous (ratio ∼1). Notably, crystallinity
typically developed at λ > 4, most pronounced for for γ-PGA-Et for reasons which are not
yet clear.
Figure 5.14: First-heating DSC thermograms of γ-PGA-Et films drawn to λ = 10.
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Figure 5.15: First-heating DSC thermograms of γ-PGA-Pr films drawn to λ = 10.
Figure 5.16: First-heating DSC thermograms of γ-PGA-Bn films drawn to λ = 10.
129
5 Enhancing mechanical properties of esterified γ-PGA polymers using tensile deformation
Table 5.9: Normalised endotherm/exotherm ratios for γ-PGA films drawn to λ = 10.
Draw ratio / λ γ-PGA-Et γ-PGA-Pr γ-PGA-Bn
1 (as-cast) 1.53 1.63 1.35
2 1.81 1.58 1.44
4 3.65 1.69 1.58
6 6.54 1.95 1.85
8 14.10 2.38 2.26
10 28.68 3.11 2.80
5.5 Conclusions
In this chapter, solution-cast films of native and esterified γ-PGA were subject to tensile
testing at room temperature to explore their mechanical properties. Due to hydrogen
bonding between chains, the unmodified γ-PGA-H film was found to be brittle at room
temperature with a Young’s modulus of ∼5 GPa, tensile strength of 94 MPa and 2% strain
at break. By contrast, all modified γ-PGA polymers were found to be very ductile at room
temperature, displaying an inverse relationship between side group size and strain at break
of 542%, 361%, and 106% for γ-PGA-Et, γ-PGA-Pr, and γ-PGA-Bn films, respectively.
Unoriented γ-PGA-Et films concomitantly displayed the lowest values of E = 0.85 GPa,
σy = 14.7 MPa.
Subsequently, solution-cast films of the esterified γ-PGA were oriented by tensile defor-
mation between their glass transition temperature Tg and peak crystallisation temperature
Tc to increase their (uniaxial) macromolecular order and, accordingly, their mechanical
properties. An increase in stiffness was achieved for γ-PGA-Bn, reaching a value of the
Young’s modulus of over 5 GPa, tensile strength of nearly 150 MPa, and a strain at break
of 7.25%. It was been demonstrated that the mechanical characteristics of these polymers
can be tailored over a wide range for desired bioapplications.
It was shown by WAXS that γ-PGA-Et, γ-PGA-Pr, and γ-PGA-Bn polymers form α-
helical structures, whereas the main chain conformation remains close to planar. The
proposed orientation of hydrogen bonds was confirmed by polarised Raman spectroscopy.
The unit cells of all three esterified polymers are orthorhombic, containing 4 monomers.
The a-parameter was found to be affected by the lateral chain size, which indicates that the
changes in the chemical structure are accommodated within the sheet planes by increasing
the inter-chain distance.
Finally, esterification of γ-PGA polymers expectedly shielded of the H-bonds present
in the unmodified form. This allowed tailoring of their mechanical properties over an
exceptional range by tensile deformation. Taken together, these results may hold promise
for use in tissue engineering applications, where mechanically appropriate, biodegradable
scaffolds are required.
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Chapter 6
Scaling up γ-PGA-Bn synthesis
6.1 Introduction
The next stage of this thesis was to scale up esterified γ-PGA synthesis. Following the
synthesis described in Chapter 2, the total amount of material produced was roughly 1.5-
1.7 g, with a 60-70% yield. Furthermore, batch-to-batch variation in degree of esterifica-
tion had a prominent effect on thermal properties as well as the weight average molecular
weight (Mw) of the polymers.
Previously discussed in Chapter 5, this variability in Mw would result in different me-
chanical properties. As a result, tensile deformation studies were limited by the mass of
material from a single batch and would benefit from increasing produced quantities.
Similarly, in order to perform quantitative cellular studies, it is vital to increase the
synthesis to produce an abundance of material. This will enable fabrication of several
scaffolds with sufficient size and similar mechanical properties. Furthermore, more ma-
terial is required to perform cellular studies which investigate any effect from varying the
degree of γ-PGA-Bn polymer orientation.
In theory, as the esterification procedure is performed on a molar-ratio basis, the reac-
tion should be easily scalable. In practice, however, this requires new equipment, handling
of large volumes for purification, and safely disposing of waste quantities. This chapter
reports chemical, thermal and structural characterisation of scaled γ-PGA-Bn syntheses.
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6.2 Experimental
6.2.1 Chemical synthesis
General
All starting polymer (γ-D,L-PGA Na+ salt, produced by Bacillus subtilis) was purchased
from Natto Biosciences (Shanghai, China). All reagents and solvents were purchased
from Aldrich and used as received, unless otherwise specified.
Free acid form of γ-PGA
Similar to synthesis in Section 2.2.1, γ-PGA Na+ salt (40 g) was dissolved in 1 L of
distilled water. The solution was acidified with HCl 6M to pH 1.5, distributed in 75 ml
volumes, frozen at -80°C and lyophilised for at least 96 h. The freeze-dried solid resulted
soft and porous.
γ-PGA esterification
Batches of 3, 4, or 5-times the quantity of polymers detailed in Section 2.2.1 were syn-
thesised using a SC162 temperature regulated stirrer hot plate (complete with SCT1 tem-
perature controller; Bibby Scientific Limited; Stone, U.K.) with an oil bath for even,
controlled heating of the solutions. γ-PGA free acid (+ NaCl) (7.2, 9.6, or 12 g, for 3x,
4x and 5x, respectively; all 0.01 M) was introduced into a 1000 mL round bottom flask
equipped with a temperature regulated stirrer hot plate, and suspended in 540, 720, or 900
mL of anhydrous NMP. The suspension was heated by oil bath to 80°C and stirred for 24
h to dissolve the γ-PGA-H. After that time, the mixture was cooled to 60°C and NaHCO3
(12.9, 17.2, or 21.5 g as 0.85 M, 1.14 M, or 1.42 M, respectively) was added. After 2
h, the benzyl bromide was added dropwise (22.8, 30.4, or 38 mL, respectively) to the
mixture for a 5x molar excess over 5 min. The mixture was stirred at 60°C for a period of
time ranging from 36 to 40 h. The reaction was quenched by removing the round bottom
flask from the oil bath, cooling to room temperature and stirring stopped. The withdrawal
for 1H-NMR was precipitated and degree of esterification calculation was calculated as
in Section 2.2.1. If the degree of esterification was below 100%, the NMP solution was
re-heated to 60°C, stirring, and 1 molar equivalent of bromide was added. The reaction
continued for 24 h, after which another NMR sample was withdrawn as before.
Following confirmation of reaction esterification by 1H-NMR, the reacted γ-PGA /NMP
supernatant was decanted at a ratio of 1:10 NMP:cold HCl (pH 1.5) into 5 L beakers (final
volume per beaker up to 4.25 L), and left to precipitate overnight at 4°C. The remaining
salts (NaHCO3 and NaBr) were discarded. The sticky precipitate was filtered on a glass
filter (1 L, Por 3), washed with cold diH2O (1.5-3 L), followed by an equal volume of
diethyl ether, soaked in 500 mL diethyl ether for 1-3 h, filtered again, and finally dried on
the filter at RT overnight in the fume cupboard.
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Purification
The esterified γ-PGA was dissolved in dried DMSO (0.2-0.5% final solution; SeccoSolv®,
Merck; chemical provided by VWR) by mild heating (40°C) and stirring. The solution
was then precipitated 1:10 in diH2O for at least 6 h after which 3 drops of 6M HCl were
added to clarify the solution and encourage precipitation. The solid was filtered on a glass
filter (as before), repeatedly washed with H2O and Et2O, and then dried at RT overnight
in the fume cupboard.
6.2.2 Characterisation
All polymers produced were characterised as previously stated in Chapter 2 using 1H-
NMR, SEC, TGA, and DSC.
1H-NMR
All polymer batches were characterised using 1H-NMR as in Chapter 2 and found to be
fully esterified.
6.3 Results
6.3.1 Synthesis
All batches produced in this chapter were found to have a yield of 90-95%, a large im-
provement on those produced in Chapter 2 (60-70%). This increase is most likely at-
tributed to the new hotplate/stirrer setup with a temperature regulated feedback system,
which ensured reactions were maintained at 60°C using oil baths. The previous setup
used and discussed in Chapter 2 was set to 60°C, yet was still liable to environmental
temperature variations. This may have had an effect on a steady oil bath temperature, but
was no longer a concern with the new feedback controlled system.
6.3.2 1H-NMR
All polymer batches (γ-PGA-Bn-3 - γ-PGA-Bn-8) were fully esterified as calculated by
1H-NMR integration.
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Figure 6.1: 1H-NMR for γ-PGA-Bn scaled up batches (DMSO-d6, 25°C).
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6.3.3 Size exclusion chromatography
The molecular weight distributions of the γ-PGA-Bn batches were determined using SEC
as reported in Section 2.3.4. All esterified γ-PGA polymer results are relative to PMMA
standards (in DMF with 1g/L LiBr). As discussed in Chapter 2, the starting, bacterially
produced γ-PGA-H polymer has a high weight average molecular weight Mw of γ-PGA-H
is 2.83 x 105, with a fairly broad distribution as shown in its’ polydispersity index (PDI,
2.40).
Scaling up of synthesis appeared to have a small effect on the weight average molecular
weight and a larger effect on its distribution. Measured Mw varied from 9.20 x 104 to
2.48 x 105 with polydispersities within the range of 3.08-3.56. The γ-PGA-Bn polymers
presented in Section 2.3.4 had similar values of Mw (ranging 8.67 x 104 to 1.46 x 105), but
with less polydispersity amongst the batches than scaled batches. This increased P.D.I. in
scaled up batches may also have an effect on mechanical properties.
Therefore, in the future, it would be advantageous to run the polymer through a prepar-
ative SEC column and collect fractions to reduce the variation in Mw. This would espe-
cially be useful in future mechanical studies, including tensile deformation. The selection
of column would need to take into account both the polymer’s limited solubility in organic
solvents, and the toxicity of LiBr, which is used with this SEC.
Table 6.1: SEC results for scaled up γ-PGA-Bn series polymers.
Polymer Synthesis Mn/g mol−1 Mw/g mol−1 P.D.I.
γ-PGA-Bn 3 2.94 x 104 9.20 x 104 3.12
4 3.71 x 104 1.25 x 105 3.36
5 4.78 x 104 1.70 x 105 3.56
6 3.36 x 104 1.03 x 105 3.08
7 7.43 x 104 2.48 x 105 3.33
8 4.80 x 104 1.69 x 105 3.54
6.3.4 Thermal characterisation
Thermal characterisation was performed on the produced polymer powders. Both TGA
and DSC analysis are tabulated in Table 6.2, along with the two γ-PGA-Bn batches pro-
duced in Chapter 2 (γ-PGA-Bn-1 and γ-PGA-Bn-2). These results demonstrate there is
little thermal variation between the scaled up batches, unlike those produced in Chapter
2.
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Table 6.2: Thermal characterisation of all γ-PGA-Bn batches, where Tc represents crys-
tallisation upon cooling.
Synthesis Tg /°C Tc /°C Tm 1 /°C Tm 2 /°C 5% Td /°C
1 55 163 224 217 244
2 50 156 221 212 236
3 64 168 225 223 256
4 66 168 225 223 258
5 62 169 227 224 254
6 66 169 227 224 257
7 64 170 225 224 258
8 64 169 225 222 254
Thermogravimetric analysis
Thermogravimetric analyses (TGA) were performed on all γ-PGA-Bn polymers to deter-
mine any variation in temperatures of thermal degradation. The values at which polymers
experienced 5% decomposition are presented in Table 6.2 with DSC thermal character-
isation results. All scaled up batches had a 5% Td of 256°C ± 1.8°C. This shows an
overall increase in 5% Td and decrease in variability when compared to that of the mea-
sured values for γ-PGA-Bn-1 and γ-PGA-Bn-2 produced in Chapter 2 (244°C and 236°C,
respectively). This change is reasonably due to the increased degree of esterification of
scaled γ-PGA-Bn batches (100% by 1H-NMR integration). Recalling the degree of ester-
ification achieved in Chapter 2 (γ-PGA-Bn-1 = 99% while γ-PGA-Bn-2 = 96%), it may
be concluded that an increase in degree of conversion also results in more resistance to de-
polymerisation of the main chain. Taken together, these results support the experimentally
observed increase in the onset of 5% thermal degradation.
Differential scanning calorimetry
Differential scanning calorimetry (DSC) was employed to determine the transition tem-
peratures of the scaled γ-PGA-Bn polymers. DSC was performed on purified powders
and the heating/cooling rates were kept at 10°C min−1. All heating traces of esterified
polymers are presented in Figure 6.2 and the results tabulated in Table 6.2.
All the Tg values of scaled batches increased to 62-66°C with little variability. This
was also found to be the case with other thermal transition temperatures, namely recrys-
tallisation (Trc) and Tm. As seen in Table 6.2 the 5% Td is higher for scaled up polymers,
indicating they experience less degradation at the melting temperature. The increased
range between Tm and 5% Td explains the decrease in magnitude of Tm shift seen in the
second heating runs. All of these results obtained from DSC are expected with an in-
crease in level of esterification, as well as more regularity of the polymer main chain.
The repeatability of synthesis characteristics, regardless of reaction size, presents a very
encouraging outcome when compared with the variability seen in Chapter 2.
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Figure 6.2: DSC heating traces for γ-PGA-Bn scaled up batches where black indicates
first heating and red is the second.
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6.3.5 Density measurements
Finally, the densities of scaled γ-PGA-Bn polymers were calculated using gas pycnome-
try. The values measured are listed in Table 6.3 and the density of γ-PGA-Bn (scaled) was
found to be 1.400 ± 0.011 g cc−1. This may be related to the degree of modification as
chain regularity is known to affect polymer crystal packing. Thus, repeatable, full modifi-
cation of scaled γ-PGA-Bn batches also allows increased reproducible polymer densities.
Chain regularity and degree of crystallinity have a direct effect on mechanical properties,
as discussed in Chapter 5, thus consistent batches are more ideal for mechanical testing.
Table 6.3: Density of all γ-PGA-Bn scaled-up batches.
Synthesis Batch size Density /g cc-1
3 4x 1.398
4 3x 1.400
5 5x 1.399
6 5x 1.388
7 5x 1.420
8 5x 1.393
Overall, by changing the experimental equipment, the syntheses now reproducibly
yields more product with very little variability between batches. Using a temperature-
regulated feedback hotplate stirrer in this chapter substantially improved the synthesis.
Thus it is thought that this esterification is particularly sensitive to temperature changes.
The work shown here also demonstrates that laboratory synthesis may be scaled, but is
limited to equipment size within a laboratory setting. Therefore, this synthesis may poten-
tially be performed on a small industrial scale, with limiting factors being solvent waste
removal and polymer purification on a larger scale.
6.4 Conclusions
This chapter presented six successful syntheses of γ-PGA-Bn in larger quantities than
those in Chapter 2. Reactions of 3, 4, and 5 times the quantity in Chapter 2 displayed
both a high yield and repeatability, independent of overall starting volume. Polymer Mw
were maintained above 90,000 Da with a slight increase in polydispersity, and thus would
benefit from fraction collection for a more narrow Mw range prior to processing. Batches
produced here had a higher level of esterification, resulting in an increase in thermal
properties, namely Tg and 5% Td. Similarly, less degradation occurred with melting and
polymer density had little variability between all batches. These improvements in batch
consistency seen in this chapter are due to changing the experimental setup, indicating this
reaction is enhanced with maintaining a continual reaction temperature. Though limited to
a laboratory setting, this work demonstrates the ability to increase yield and total product,
implying it may be scaled to an industrial size if waste removal can be optimised.
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Conclusions and outlook
Tissue engineering has the potential to change modern medicine as we know it. Research
in regenerative medicine focuses highly on biomaterials which have the ability to guide
the body to repair itself, providing a degradable scaffold that encourages ingrowth. The
aim of the work presented in this thesis was to address four ideal qualities of engineered
constructs: biodegradability, biocompatibility, appropriate mechanical properties, and tai-
lorability. To do this, a naturally-produced polyamino acid, poly(gamma-D,L-glutamic
acid; γ-PGA) was utilised as it is non-toxic, enzymatically degraded, and relatively unex-
plored in tissue engineering applications.
Initially, to limit the high water solubility of γ-PGA, the side chain was esterified using
either an alkyl or aryl group as previously reported. [146] Following acidification to yield
a reactive, free -COOH side group, over 90% modification of γ-PGA was achieved using
ethyl, propyl, or benzyl bromide, yielding γ-PGA-Et, γ-PGA-Pr, or γ-PGA-Bn, respec-
tively. A high weight average molecular weight (≥105 Da) was maintained throughout the
synthesis. Attributed to a reduction in H-bonds between chains, esterification introduced
more macromolecular order and caused a drop in the glass transition temperature (Tg) of
all modified polymers when compared with the native acid form (γ-PGA-H). Modifying
the side chain also led to a large increase in the onset of 5% thermal degradation (Td),
opening a wider range for thermal processing of the polymers. Contact angle increased
with increasing side chain hydrophobicity and values for γ-PGA-Bn were found to be
similar to that of FDA approved poly(L-lactic acid; PLLA).
Unfortunately, the discovery of degradation upon melting eliminated the possibility
of using traditional polymer melt-processing techniques. Furthermore, limited quantities
of material were produced per synthesis, at a yield of 60-70%. Variability in degree
of esterification between batches, attributed to the experimental equipment used for the
reaction, inhibited combining multiple syntheses for other studies.
Next, in an alternative approach to γ-PGA modification, the native γ-PGA-H polymer
was altered by using a carbodiimide to couple L-phenylalanine-NH2 (generating γ-PGA-
Phe) to the free -COOH side group. A one-step synthesis only yielded γ-PGA-Phe with
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roughly 30% degree of coupling. Therefore, a two-step synthesis was employed: firstly
reacted in a mixture of aqueous/organic solvent and purified, followed by a reaction in
only organic solvent. Fully coupled, the γ-PGA-Phe had several impurities from the re-
action, most notably the poorly soluble byproduct dicyclohexylurea (DCU). As DCU is
very difficult to remove from the γ-PGA-Phe, the synthesis will likely benefit from using
a different carbodiimide which yields an easily removable urea.
Addition of the L-phenylalanine-NH2 caused an increase in Tg to 156 °C, due to the
introduction of more hydrogen bonding. Similar then to the γ-PGA-H, this polymer is
expected to be very brittle at RT and anticipated to have a Young’s modulus over 5 GPa.
Further synthesis, in larger quantities, is necessary to produce enough material for me-
chanical testing to test this hypothesis.
To date, this is first time γ-PGA-H has been fully modified using phenylalanine. Though
the Akashi group have published several papers on amphiphilic nanoparticles made of
53% coupled γ-PGA, they use an ethyl ester-modified L-phenylalanine. [162–170] There-
fore, this two-step synthesis opens the possibility for full functionalisation of γ-PGA with
other amino acids or even short peptide sequences to better mimic the extracellular matrix
of a target replacement tissue.
Biocompatibility of esterified γ-PGA films (as-cast) was tested and all polymer films
passed the ISO 10993:5 cytotoxicity test, often used by industry as a prelude to in vivo
studies. This indicated the films do not release any toxic byproducts. Furthermore, all
films supported human fibroblast attachment and proliferation, with cells viable up to
seven days.
As found in chapter 2, the contact angle of γ-PGA-Bn, 88.1° ± 1.2, was also similar
to that of a polymer studied recently by Joy et al. [172], whose quantitative cell studies
indicated this polymer had improved cell attachment and proliferation when compared
with polymers having similar contact angles to γ-PGA-Et and γ-PGA-Pr. Therefore, γ-
PGA-Bn was chosen to subsequently focus on for further cell and dissolution studies.
Human foreskin fibroblasts formed well defined actin stress fibres colocalised with focal
adhesions when cultured on γ-PGA-Bn films, indicating the cells were well adhered to
the substrates.
After 28 days incubation at 37°C, γ-PGA-Bn films soaked in H2O, phosphate buffered
saline (PBS) or simulated body fluid (SBF) all lost ∼4% of their starting weight. Regard-
less of soaking media, films became opaque at seven days while submicron holes were
detected in the film surfaces using scanning electron microscopy. By day 28, an increased
amount of surface dissolution was visible on films soaked in salt-containing media (PBS
and SBF). As most mass was maintained, the γ-PGA-Bn should mainly be degraded by
enzymes. Thus, in vivo testing of γ-PGA-Bn is required to assess this polymer’s implan-
tation lifetime.
Following chemical synthesis and biological characterisation, mechanical properties
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of solution-cast, esterified γ-PGA polymer films were determined used tensile testing at
RT. The native γ-PGA-H was found to be brittle, with a Young’s modulus of ∼5 GPa, 94
MPa tensile strength, and only 2% strain at break due to interchain hydrogen bonding.
Esterification introduced ductility to all three polymer types, with an inverse relationship
between strain at break and side group size, i.e. 542%, 361%, and 106% for γ-PGA-Et,
γ-PGA-Pr, and γ-PGA-Bn films, respectively.
To maximise their mechanical properties by increasing overall macromolecular order,
these as-cast, modified γ-PGA films were subsequently subjected to uniaxial tensile de-
formation at temperatures between Tg and peak crystallisation temperature Tc. Able to be
drawn over 10 times, all polymers experienced an increase in stiffness and tensile strength
while strain at break was maintained at or above a physiologically relevant 7.25%. γ-
PGA-Bn had the highest Young’s modulus of over 5 GPa, with a tensile strength of nearly
150 MPa.
Depending on choice of side group or degree of induced orientation, mechanical char-
acteristics of these polymers can be tailored over a wide range for desired bioapplications.
This ability could potentially be expanded by also tailoring the weight-average molecular
weight of synthesised batches, opening more options of tissues to target for regeneration.
A similar issue arose with both mechanical and biocompatibility testing: limited mate-
rial quantity with synthesis batch variability. Thus, this work finally focused upon scaling
up the synthesis in an approach to further product development towards industry. Addi-
tionally, a temperature-regulated feedback stirrer hotplate was employed to reduce batch-
to-batch synthesis variation. Using the new setup regularly produced over 12 g of fully-
esterified γ-PGA-Bn with an increased yield (up to 94%). This work demonstrated the
reaction may be scaled, though this was the size limit of the reaction setup. The synthesis
may benefit further from using sealed, pressurised filtration for ease of waste disposal and
removal of impurities.
The work performed in this thesis centres around modifying γ-PGA for use in regen-
erative medicine applications. As shown in this work, by varying side-group chemistry
or molecular alignment, properties of modified γ-PGA polymers may be designed to suit
specific applications, thus addressing four important tissue engineering requirements: tai-
lorability, appropriate mechanical properties, biocompatibility, and biodegradability.
If more time were available, it would have been optimal to produce larger, aligned γ-
PGA-Bn scaffolds for further testing. More in-depth cell studies (cell interaction studies,
including cell proliferation, extracellular matrix protein characterisation, genetic expres-
sion, and imaging on oriented polymer samples using both primary and stem cells for
successful implant growth) would be performed to determine the abilities of the different
polymers to support cell growth and structuring. This would also ascertain which tissues
would be best to target so that the scaffolds may be carried forward towards commer-
cialisation. Optimisation of polymer purification, including fraction collection to reduce
141
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polydispersity, would be highly pertinent for making reproducible scaffolds in a prelude
to manufacturing medical products.
Different cell types would provide information about the abilities of the scaffold to sup-
port growth of various tissues for different biological sites and organs. As the modified
γ-PGA polymers are enzymatically degraded, an ideal outcome would include optimisa-
tion of material properties to be subsequently tested in vivo for determining the implanted
scaffold’s lifetime, as well as assess performance and tissue ingrowth.
Finally, it would also have been advantageous to produce larger quantities of the fully-
modified γ-PGA-Phe in order to test the mechanical properties and biocompatibility of
this material. Equally as interesting, conjugating short peptide sequences to the γ-PGA
and seeing their effect on cell growth would have opened the possibility for wider tissue
engineering applications. As this material has such high potential in tissue engineering,
with numerous possibilities to functionalise, an abundance of related future work possi-
bilities exist.
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